# EDGAR Filing Document

**Accession Number:** 0001640967
**File Stem:** 0001628280-26-035468
**Filing Date:** 2026-5
**Character Count:** 153223
**Document Hash:** 51b4f746ed77cc51c62de3946aab6f2e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-035468.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001628280-26-035468

**CONFORMED SUBMISSION TYPE**: 253G2

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Rise Companies Corp
- **CENTRAL INDEX KEY:** 0001640967
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 454862460
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 253G2
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 024-12664
- **FILM NUMBER:** 26985396

**BUSINESS ADDRESS:**
- **STREET 1:** 11 DUPONT CIRCLE NW
- **STREET 2:** 9TH FLOOR
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036
- **BUSINESS PHONE:** 2025840550

**MAIL ADDRESS:**
- **STREET 1:** 11 DUPONT CIRCLE NW
- **STREET 2:** 9TH FLOOR
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036

**Filed Pursuant to Rule 253(g)(2)**

**File No. 024-12664**

**RISE COMPANIES CORP.**

**SUPPLEMENT NO. 2 DATED MAY 15, 2026** 

**TO THE OFFERING CIRCULAR DATED SEPTEMBER 24, 2025**

This document supplements, and should be read in conjunction with, the offering circular of Rise Companies Corp. (the "<u>Company</u>", "<u>we</u>", "<u>our</u>" or "<u>us</u>"), dated September 24, 2025 and filed by us with the Securities and Exchange Commission (the "<u>Commission</u>") on September 24, 2025, as previously amended or supplemented (the "<u>Offering Circular</u>"). Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circular.

The purpose of this supplement is to disclose as an appendix the information contained in the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2026.

------

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| <u>[Statements Regarding Forward-Looking Information](#i010073027201481f91c7f293a54ba05a_10)</u> | <u>[Statements Regarding Forward-Looking Information](#i010073027201481f91c7f293a54ba05a_10)</u> | <u>[1](#i010073027201481f91c7f293a54ba05a_10)</u> |
| **<u>[PART I](#i010073027201481f91c7f293a54ba05a_13)</u>** | **<u>[FINANCIAL INFORMATION](#i010073027201481f91c7f293a54ba05a_13)</u>**  | <u>[3](#i010073027201481f91c7f293a54ba05a_13)</u> |
| <u>[Item 1.](#i010073027201481f91c7f293a54ba05a_16)</u> | <u>[Unaudited Financial Statements](#i010073027201481f91c7f293a54ba05a_16)</u> | <u>[3](#i010073027201481f91c7f293a54ba05a_16)</u> |
| <u>[Item 2.](#i010073027201481f91c7f293a54ba05a_85)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i010073027201481f91c7f293a54ba05a_85)</u> | <u>[28](#i010073027201481f91c7f293a54ba05a_85)</u> |
| <u>[Item 3.](#i010073027201481f91c7f293a54ba05a_106)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i010073027201481f91c7f293a54ba05a_106)</u> | <u>[35](#i010073027201481f91c7f293a54ba05a_106)</u> |
| <u>[Item 4.](#i010073027201481f91c7f293a54ba05a_109)</u> | <u>[Controls and Procedures](#i010073027201481f91c7f293a54ba05a_109)</u> | <u>[35](#i010073027201481f91c7f293a54ba05a_109)</u> |
| **<u>[PART II](#i010073027201481f91c7f293a54ba05a_112)</u>** | **<u>[OTHER INFORMATION](#i010073027201481f91c7f293a54ba05a_112)</u>**  | <u>[37](#i010073027201481f91c7f293a54ba05a_112)</u> |
| <u>[Item 1.](#i010073027201481f91c7f293a54ba05a_115)</u> | <u>[Legal Proceedings](#i010073027201481f91c7f293a54ba05a_115)</u> | <u>[37](#i010073027201481f91c7f293a54ba05a_115)</u> |
| <u>[Item 1A.](#i010073027201481f91c7f293a54ba05a_118)</u> | <u>[Risk Factors](#i010073027201481f91c7f293a54ba05a_118)</u> | <u>[37](#i010073027201481f91c7f293a54ba05a_118)</u> |
| <u>[Item 2.](#i010073027201481f91c7f293a54ba05a_121)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i010073027201481f91c7f293a54ba05a_121)</u> | <u>[37](#i010073027201481f91c7f293a54ba05a_121)</u> |
| <u>[Item 3.](#i010073027201481f91c7f293a54ba05a_124)</u> | <u>[Defaults Upon Senior Securities](#i010073027201481f91c7f293a54ba05a_124)</u> | <u>[38](#i010073027201481f91c7f293a54ba05a_124)</u> |
| <u>[Item 4.](#i010073027201481f91c7f293a54ba05a_127)</u> | <u>[Mine Safety Disclosures](#i010073027201481f91c7f293a54ba05a_127)</u> | <u>[38](#i010073027201481f91c7f293a54ba05a_127)</u> |
| <u>[Item 5.](#i010073027201481f91c7f293a54ba05a_130)</u> | <u>[Other Information](#i010073027201481f91c7f293a54ba05a_130)</u> | <u>[38](#i010073027201481f91c7f293a54ba05a_130)</u> |

---

i

------

**STATEMENTS REGARDING FORWARD-LOOKING INFORMATION**

Rise Companies Corp. ("Rise," "Rise Companies," "we," "our," the "Company," and "us") makes statements in this Quarterly Report on Form 10-Q (the "Quarterly Report") that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The words "believe," "estimate," "expect," "anticipate," "intend," "plan," "seek," "may," and similar expressions or statements regarding future periods are intended to identify forward-looking statements. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and are including this statement for purposes of complying with those safe harbor provisions. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any predictions of future results, performance or achievements that we express or imply in this Quarterly Report or in the information incorporated by reference into this Quarterly Report.

The forward-looking statements included in this Quarterly Report are based upon our current expectations, plans, estimates, assumptions and beliefs that involve numerous risks and uncertainties, and accordingly we can give no assurance that such expectations, plans, estimates, assumptions and beliefs are correct or will be achieved. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Although we believe that the expectations reflected in such forward-looking statements are based on reasonable assumptions, our actual results and performance could differ materially from those set forth in the forward-looking statements. Factors which could have a material adverse effect on our and our Investment Products' (as defined within *<u>[Note 1](#i010073027201481f91c7f293a54ba05a_34)</u>, Formation and Organization,* in our Condensed Consolidated Financial Statements) operations and future prospects include, but are not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our dependence on fee income generated from our Investment Products to support our continued growth and expansion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to attract and retain shareholders to the online investment platform located at *<u>www.fundrise.com</u>* (the "Fundrise Platform");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with breaches of our data security;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in economic conditions generally and in the real estate and securities markets specifically;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• uncertainty regarding geopolitical tensions, tariff and trade policies and impacts from any such policies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• limited ability of our Investment Products to dispose of assets, on terms acceptable to us or at all, because of the relative illiquidity of alternative investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• intense competition in the real estate market that may limit the ability of our Investment Products to attract or retain tenants or re-lease space;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increased inflation and related impacts, including increased interest rates and operating costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to retain our executive officers and other key personnel of Fundrise Advisors, LLC and our other affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to retain and hire competent employees and appropriately staff our operations;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in business conditions and the market value of our and our Investment Products' assets, including changes in interest rates, prepayment risk, operator or borrower defaults or bankruptcy, and generally the increased risk of loss if our investments fail to perform as expected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to implement effective conflicts of interest policies and procedures among the various investment opportunities sponsored by the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability of our Investment Products to access sources of liquidity when we have the need to fund redemptions of common shares in excess of the proceeds from the sales of their common shares in our offerings or funds from our operations and the consequential risk that we may not have the resources to satisfy redemption requests;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our compliance with applicable local, state and federal laws, including the Investment Advisers Act of 1940, as amended (the "Advisers Act"), the Investment Company Act of 1940, as amended (the "Investment Company Act") and other laws; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the other risks identified in this Quarterly Report and our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission ("SEC") on March 23, 2026 (the "Form 10-K"), which may be accessed <u>[here](https://www.sec.gov/ix?doc=/Archives/edgar/data/1640967/000162828026020484/rc-20251231.htm)</u>, including, without limitation, those under headings "Risk Factors" and "Business".

Any of the assumptions underlying forward-looking statements could be inaccurate. You are cautioned not to place undue reliance on any forward-looking statements included in this Quarterly Report. All forward-looking statements are made as of the date of this Quarterly Report and the risk that actual results will differ materially from the expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation to publicly update or revise any forward-looking statements after the date of this Quarterly Report, whether as a result of new information, future events, changed circumstances or any other reason. In light of the significant uncertainties inherent in the forward-looking statements included in this Quarterly Report, the inclusion of such forward-looking statements should not be regarded as a representation by us or any other person that the objectives and plans set forth in this Quarterly Report will be achieved.

------

**PART I - FINANCIAL INFORMATION**

**Item 1. Unaudited Financial Statements.**

**INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF RISE COMPANIES CORP.** 

**(Unaudited)**

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;&nbsp;&nbsp;**<u>Page</u>** |
| <u>[Condensed Consolidated Balance Sheets](#i010073027201481f91c7f293a54ba05a_19)</u> | <u>[4](#i010073027201481f91c7f293a54ba05a_19)</u> |
| <u>[Condensed Consolidated Statements of Operations](#i010073027201481f91c7f293a54ba05a_22)</u> | <u>[5](#i010073027201481f91c7f293a54ba05a_22)</u> |
| <u>[Condensed Consolidated Statements of Changes in Convertible Preferred Stock, Stockholders' Equity and Non-Controlling Interest](#i010073027201481f91c7f293a54ba05a_25)</u> | <u>[6](#i010073027201481f91c7f293a54ba05a_25)</u> |
| <u>[Condensed Consolidated Statements of Cash Flows](#i010073027201481f91c7f293a54ba05a_28)</u> | <u>[7](#i010073027201481f91c7f293a54ba05a_28)</u> |
| <u>[Notes to Condensed Consolidated Financial Statements](#i010073027201481f91c7f293a54ba05a_31)</u> | <u>[8](#i010073027201481f91c7f293a54ba05a_31)</u> |

---

------

**RISE COMPANIES CORP.** 

**Condensed Consolidated Balance Sheets** 

*(Amounts in thousands, except share data)*

---

| | | |
|:---|:---|:---|
| | **March 31, 2026**<br>**(Unaudited)** | **December 31, 2025**<br>**(\*)** |
| **<u>ASSETS</u>** | | |
| **Current assets:** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $&nbsp;&nbsp;&nbsp;&nbsp;7128&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;9248&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | &nbsp;&nbsp;&nbsp;&nbsp;599&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;131&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Due from affiliates | &nbsp;&nbsp;&nbsp;&nbsp;8504&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;6937&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | &nbsp;&nbsp;&nbsp;&nbsp;1894&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;1606&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes receivable | &nbsp;&nbsp;&nbsp;&nbsp;10569&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;13069&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets, net | &nbsp;&nbsp;&nbsp;&nbsp;3305&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;2651&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total current assets**  | **&nbsp;&nbsp;&nbsp;&nbsp;31999&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;33642&nbsp;&nbsp;&nbsp;&nbsp;** |
| Investments in Sponsored Programs | &nbsp;&nbsp;&nbsp;&nbsp;1391&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;1371&nbsp;&nbsp;&nbsp;&nbsp; |
| Property, software and equipment, net | &nbsp;&nbsp;&nbsp;&nbsp;24482&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;28783&nbsp;&nbsp;&nbsp;&nbsp; |
| Operating lease assets | &nbsp;&nbsp;&nbsp;&nbsp;2795&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;2915&nbsp;&nbsp;&nbsp;&nbsp; |
| Other assets, net | &nbsp;&nbsp;&nbsp;&nbsp;3232&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;3370&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total assets** | **$&nbsp;&nbsp;&nbsp;&nbsp;63899&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;70081&nbsp;&nbsp;&nbsp;&nbsp;** |
| **<u>LIABILITIES</u>** |  |  |
| **Current liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $&nbsp;&nbsp;&nbsp;&nbsp;2002&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;528&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | &nbsp;&nbsp;&nbsp;&nbsp;2913&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;7769&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities, current | &nbsp;&nbsp;&nbsp;&nbsp;1056&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;1049&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | &nbsp;&nbsp;&nbsp;&nbsp;1872&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;1451&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total current liabilities**  | **&nbsp;&nbsp;&nbsp;&nbsp;7843&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;10797&nbsp;&nbsp;&nbsp;&nbsp;** |
| Operating lease liabilities, non-current | &nbsp;&nbsp;&nbsp;&nbsp;3233&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;3426&nbsp;&nbsp;&nbsp;&nbsp; |
| Other liabilities | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;292&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total liabilities** | **&nbsp;&nbsp;&nbsp;&nbsp;11076&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;14515&nbsp;&nbsp;&nbsp;&nbsp;** |
| *Commitments and contingencies (<u>[Note 16](#i010073027201481f91c7f293a54ba05a_79)</u>)* |  |  |
| Series A convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized; 11,865,046 shares issued and outstanding; with an aggregate liquidation preference of $25,951 | &nbsp;&nbsp;&nbsp;&nbsp;25018&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;25018&nbsp;&nbsp;&nbsp;&nbsp; |
| **<u>STOCKHOLDERS' EQUITY</u>** |  |  |
| Class A Common Stock, $0.0001 par value; 43,000,000 shares authorized; 2,891,359 shares issued and 2,458,394 shares outstanding | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |
| Class B Common Stock, $0.0001 par value; 38,000,000 shares authorized, 22,207,313 shares issued and 20,056,589 outstanding, 21,970,987 shares issued and 19,826,469 outstanding, respectively | &nbsp;&nbsp;&nbsp;&nbsp;2&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;2&nbsp;&nbsp;&nbsp;&nbsp; |
| Class F Common Stock, $0.0001 par value; 10,000,000 shares authorized; 10,000,000 shares issued and outstanding | &nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp; |
| Additional paid-in capital | &nbsp;&nbsp;&nbsp;&nbsp;204248&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;200586&nbsp;&nbsp;&nbsp;&nbsp; |
| Accumulated deficit | &nbsp;&nbsp;&nbsp;&nbsp;(187714) | &nbsp;&nbsp;&nbsp;&nbsp;(182298) |
| **Total stockholders' equity before non-controlling interests**  | **&nbsp;&nbsp;&nbsp;&nbsp;16537&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;18291&nbsp;&nbsp;&nbsp;&nbsp;** |
| Non-controlling interests in consolidated entity | &nbsp;&nbsp;&nbsp;&nbsp;11268&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;12257&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total stockholders' equity**  | **&nbsp;&nbsp;&nbsp;&nbsp;27805&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;30548&nbsp;&nbsp;&nbsp;&nbsp;** |
| **Total liabilities and stockholders' equity**  | **$&nbsp;&nbsp;&nbsp;&nbsp;63899&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;70081&nbsp;&nbsp;&nbsp;&nbsp;** |

---

__________________

*\*Derived from audited financials*

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**RISE COMPANIES CORP.** 

**Condensed Consolidated Statements of Operations** 

**(Unaudited)**

*(Amounts in thousands, except share and per share data)*

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**<br>**March 31,** | **Three Months Ended**<br>**March 31,** |
| | **2026** | **2025** |
| **Revenue** | **$&nbsp;&nbsp;&nbsp;&nbsp;17529&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;11955&nbsp;&nbsp;&nbsp;&nbsp;** |
| **Costs and expenses** |  |  |
| Cost of revenue, exclusive of depreciation and amortization shown separately below | &nbsp;&nbsp;&nbsp;&nbsp;2581&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;2218&nbsp;&nbsp;&nbsp;&nbsp; |
| Technology and product development | &nbsp;&nbsp;&nbsp;&nbsp;6129&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;5560&nbsp;&nbsp;&nbsp;&nbsp; |
| Marketing | &nbsp;&nbsp;&nbsp;&nbsp;2749&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;2216&nbsp;&nbsp;&nbsp;&nbsp; |
| General, administrative and other | &nbsp;&nbsp;&nbsp;&nbsp;5845&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;5903&nbsp;&nbsp;&nbsp;&nbsp; |
| Depreciation and amortization | &nbsp;&nbsp;&nbsp;&nbsp;4474&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;3036&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total costs and expenses** | **&nbsp;&nbsp;&nbsp;&nbsp;21778&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;18933&nbsp;&nbsp;&nbsp;&nbsp;** |
| **Net operating loss** | **&nbsp;&nbsp;&nbsp;&nbsp;(4249)** | **&nbsp;&nbsp;&nbsp;&nbsp;(6978)** |
| **Other income** |  |  |
| Gain on extinguishment of debt | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;2391&nbsp;&nbsp;&nbsp;&nbsp; |
| Dividend and interest income | &nbsp;&nbsp;&nbsp;&nbsp;272&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;328&nbsp;&nbsp;&nbsp;&nbsp; |
| Equity in earnings | &nbsp;&nbsp;&nbsp;&nbsp;22&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;18&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total other income** | **&nbsp;&nbsp;&nbsp;&nbsp;294&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;2737&nbsp;&nbsp;&nbsp;&nbsp;** |
| **Net loss before income taxes** | **&nbsp;&nbsp;&nbsp;&nbsp;(3955)** | **&nbsp;&nbsp;&nbsp;&nbsp;(4241)** |
| Income tax benefit (expense) | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |
| **Net loss** | **&nbsp;&nbsp;&nbsp;&nbsp;(3955)** | **&nbsp;&nbsp;&nbsp;&nbsp;(4241)** |
| Net income attributable to non-controlling interests | &nbsp;&nbsp;&nbsp;&nbsp;129&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;162&nbsp;&nbsp;&nbsp;&nbsp; |
| **Net loss attributable to Rise Companies Corp.** | **$&nbsp;&nbsp;&nbsp;&nbsp;(4084)** | **$&nbsp;&nbsp;&nbsp;&nbsp;(4403)** |
| **Net loss per share attributable to common stockholders:** |  |  |
| Basic (in dollars per share)\* | $&nbsp;&nbsp;&nbsp;&nbsp;(0.13) | $&nbsp;&nbsp;&nbsp;&nbsp;(0.14) |
| Diluted (in dollars per share)\* | &nbsp;&nbsp;&nbsp;&nbsp;(0.13) | &nbsp;&nbsp;&nbsp;&nbsp;(0.14) |
| **Weighted average shares used to compute net loss per share attributable to common stockholders:** |  |  |
| Basic (in shares)\* | &nbsp;&nbsp;&nbsp;&nbsp;32404261&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;32546024&nbsp;&nbsp;&nbsp;&nbsp; |
| Diluted (in shares)\* | &nbsp;&nbsp;&nbsp;&nbsp;32404261&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;32546024&nbsp;&nbsp;&nbsp;&nbsp; |

---

__________________

*\*Basic and diluted (loss) per share amounts pertain to each class of Common Stock.*

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**RISE COMPANIES CORP.**

**Condensed Consolidated Statements of Changes in Convertible Preferred Stock, Stockholders' Equity and Non-Controlling Interest**

**(Unaudited)** 

*(Amounts in thousands, except share data)*

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock**<br>**Series A** | **Preferred Stock**<br>**Series A** | **Common Stock**<br>**Class A** | **Common Stock**<br>**Class A** | **Common Stock**<br>**Class F** | **Common Stock**<br>**Class F** | **Common Stock**<br>**Class B** | **Common Stock**<br>**Class B** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Non- Controlling Interests** | **Total Equity** |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Non- Controlling Interests** | **Total Equity** |
| **Balance at December 31, 2025**  | **&nbsp;&nbsp;&nbsp;&nbsp;11865046&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;25018&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;2458394&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;10000000&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;19826469&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;2&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;200586&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;(182298)** | **$&nbsp;&nbsp;&nbsp;&nbsp;12257&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;30548&nbsp;&nbsp;&nbsp;&nbsp;** |
| Reclassification of Accumulated Deficit to NCI | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(1332) | &nbsp;&nbsp;&nbsp;&nbsp;1332&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |
| Issuance of Class B Common Stock | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;236326&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;3758&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;3758&nbsp;&nbsp;&nbsp;&nbsp; |
| Redemption of Class B Common Stock  | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(6206) | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(73) | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(73) |
| Offering costs for Class B Common Stock  | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(23) | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(23) |
| Distribution of Member's Equity of NCI | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(2450) | &nbsp;&nbsp;&nbsp;&nbsp;(2450) |
| Net income (loss) | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(4084) | &nbsp;&nbsp;&nbsp;&nbsp;129&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(3955) |
| **Balance at March 31, 2026** | **&nbsp;&nbsp;&nbsp;&nbsp;11865046&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;25018&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;2458394&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;10000000&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;20056589&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;2&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;204248&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;(187714)** | **$&nbsp;&nbsp;&nbsp;&nbsp;11268&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;27805&nbsp;&nbsp;&nbsp;&nbsp;** |

---

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock**<br>**Series A** | **Preferred Stock**<br>**Series A** | **Common Stock**<br>**Class A** | **Common Stock**<br>**Class A** | **Common Stock**<br>**Class F** | **Common Stock**<br>**Class F** | **Common Stock**<br>**Class B** | **Common Stock**<br>**Class B** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Non- Controlling Interests** | **Total Equity** |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Non- Controlling Interests** | **Total Equity** |
| **Balance at December 31, 2024**  | **&nbsp;&nbsp;&nbsp;&nbsp;11865046&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;25018&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;2455894&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;10000000&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;20075183&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;2&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;200811&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;(169846)** | **$&nbsp;&nbsp;&nbsp;&nbsp;11627&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;42595&nbsp;&nbsp;&nbsp;&nbsp;** |
| Issuance of Class B Common Stock | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;60596&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;963&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;963&nbsp;&nbsp;&nbsp;&nbsp; |
| Redemption of Class B Common Stock  | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(202653) | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(2174) | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(2174) |
| Offering costs for Class B Common Stock | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(21) | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(21) |
| Exercise of Common A RSOs | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;2500&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;13&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;13&nbsp;&nbsp;&nbsp;&nbsp; |
| Distribution of Member's Equity of NCI | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(53) | &nbsp;&nbsp;&nbsp;&nbsp;(53) |
| Net income (loss) | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(4403) | &nbsp;&nbsp;&nbsp;&nbsp;162&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(4241) |
| **Balance at March 31, 2025** | **&nbsp;&nbsp;&nbsp;&nbsp;11865046&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;25018&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;2458394&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;10000000&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;1&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;19933126&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;2&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;199592&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;(174249)** | **$&nbsp;&nbsp;&nbsp;&nbsp;11736&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;37082&nbsp;&nbsp;&nbsp;&nbsp;** |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**RISE COMPANIES CORP.** 

**Condensed Consolidated Statements of Cash Flows**

**(Unaudited)** 

(*Amounts in thousands*)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended**<br>**March 31, 2026** | **Three Months Ended**<br>**March 31, 2025** |
| **Cash flows from operating activities** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $&nbsp;&nbsp;&nbsp;&nbsp;(3955) | $&nbsp;&nbsp;&nbsp;&nbsp;(4241) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | &nbsp;&nbsp;&nbsp;&nbsp;4474&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;3036&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) on extinguishment of debt | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(2391) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of capitalized promotions | &nbsp;&nbsp;&nbsp;&nbsp;74&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;164&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-cash, net | &nbsp;&nbsp;&nbsp;&nbsp;(18) | &nbsp;&nbsp;&nbsp;&nbsp;10&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (increase) decrease in prepaid expenses and other assets | &nbsp;&nbsp;&nbsp;&nbsp;(1012) | &nbsp;&nbsp;&nbsp;&nbsp;(1382) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in accounts payable and accrued expenses | &nbsp;&nbsp;&nbsp;&nbsp;(3382) | &nbsp;&nbsp;&nbsp;&nbsp;(4633) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in other liabilities | &nbsp;&nbsp;&nbsp;&nbsp;61&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;386&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (increase) decrease in due from affiliates | &nbsp;&nbsp;&nbsp;&nbsp;(1567) | &nbsp;&nbsp;&nbsp;&nbsp;621&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by (used in) operating activities**  | **&nbsp;&nbsp;&nbsp;&nbsp;(5325)** | **&nbsp;&nbsp;&nbsp;&nbsp;(8430)** |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capitalized internal-use software development costs | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(2056) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from payoff of notes receivable | &nbsp;&nbsp;&nbsp;&nbsp;2500&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | &nbsp;&nbsp;&nbsp;&nbsp;(38) | &nbsp;&nbsp;&nbsp;&nbsp;(56) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by (used in) investing activities**  | **&nbsp;&nbsp;&nbsp;&nbsp;2462&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;(2112)** |
| **Cash flows from financing activities**  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution of Member's Equity of NCI | &nbsp;&nbsp;&nbsp;&nbsp;(2451) | &nbsp;&nbsp;&nbsp;&nbsp;(53) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from the issuance of Class B Common Stock, net of offering costs | &nbsp;&nbsp;&nbsp;&nbsp;3735&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;942&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Redemptions of Class B Common Stock | &nbsp;&nbsp;&nbsp;&nbsp;(73) | &nbsp;&nbsp;&nbsp;&nbsp;(1449) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payment of principal on loan payable | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(374) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from settling subscriptions | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;348&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by (used in) financing activities**  | **&nbsp;&nbsp;&nbsp;&nbsp;1211&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;(586)** |
| **Net increase (decrease) in cash and cash equivalents**  | **&nbsp;&nbsp;&nbsp;&nbsp;(1652)** | **&nbsp;&nbsp;&nbsp;&nbsp;(11128)** |
| Cash, restricted cash and cash equivalents, beginning of period  | &nbsp;&nbsp;&nbsp;&nbsp;9379&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;21155&nbsp;&nbsp;&nbsp;&nbsp; |
| **Cash, restricted cash and cash equivalents, end of period**  | **$&nbsp;&nbsp;&nbsp;&nbsp;7727&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;10027&nbsp;&nbsp;&nbsp;&nbsp;** |

---

---

| | | |
|:---|:---|:---|
| **Supplemental disclosures of cash flow information**  | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest  | $&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for income taxes  | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |

---

---

| | | |
|:---|:---|:---|
| **Supplemental disclosures of non-cash financing activity:** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Exercise of Class A Common Stock | $&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;13&nbsp;&nbsp;&nbsp;&nbsp; |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**RISE COMPANIES CORP.** 

**Notes to Condensed Consolidated Financial Statements**

**(Unaudited)**

**1. Formation and Organization**

Rise Companies Corp. ("Rise," "Rise Companies," "we," "our," the "Company," and "us") is a financial technology company that owns and operates a leading web-based and mobile application direct investment platform located at www.fundrise.com (the "Fundrise Platform").

We operate through the following significant consolidated subsidiaries, with the following activities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise, LLC ("Fundrise, LLC"), a wholly-owned subsidiary of Rise, owns and operates the Fundrise Platform that allows investors to become equity or debt holders in most of our alternative investment opportunities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Advisors, LLC ("Fundrise Advisors"), a wholly-owned subsidiary of Rise, is a registered investment adviser with the SEC that acts as the non-member manager for the fund programs sponsored by the Company and offered for investment via the Fundrise Platform.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Moat Investments, LP (f/k/a Fundrise, L.P.) ("Moat"), is an affiliate of Rise and was created with the intent to directly benefit the Company by driving its growth and profitability primarily through (i) acquisition, lending, holding, and distribution or other disposition of real estate investments, including investments in the Sponsored Programs (as defined below), and (ii) temporarily investing any idle cash. As of March 31, 2026, Rise owned approximately 2% of Moat and had the ability to direct its assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Real Estate, LLC ("Fundrise Real Estate"), a wholly-owned subsidiary of Rise, is a real estate operating platform through which many of the real estate assets of our Investment Products (as defined below) are managed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• RealAI Systems, LLC ("RealAI"), a wholly-owned subsidiary of Rise, is an artificial intelligence ("AI")-powered real estate analytics platform.

The Company has sponsored the following investment programs as of March 31, 2026, that are registered as investment companies under the Investment Company Act, and from which we generate fees related to asset management and other services performed:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Real Estate Interval Fund, LLC (the "Flagship Fund") is a Delaware limited liability company that is registered under the Investment Company Act, as a non-diversified, closed-end management investment company that is operated as an interval fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Income Real Estate Fund, LLC (the "Income Interval Fund") is a Delaware limited liability company that is registered under the Investment Company Act, as a non-diversified, closed-end management investment company that is operated as an interval fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Innovation Fund, LLC (f/k/a Fundrise Growth Tech Fund, LLC) (the "Innovation Fund" or "VCX") is a Delaware limited liability company that is registered under the Investment Company Act, as a non-diversified, closed-end management investment company. On March 19, 2026, the Innovation Fund listed on the New York Stock Exchange ("NYSE") and converted from a closed-end tender offer fund into a listed closed-end fund.

------

The Company has sponsored the following investment programs that are exempt from registration under the Securities Act as of March 31, 2026, and from which we generate fees related to asset management and other services performed:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Equity REIT, LLC, Fundrise West Coast Opportunistic REIT, LLC, Fundrise East Coast Opportunistic REIT, LLC, Fundrise Midland Opportunistic REIT, LLC, Fundrise Growth eREIT II, LLC, Fundrise Growth eREIT III, LLC, Fundrise Development eREIT, LLC, Fundrise Growth eREIT VII, LLC and Fundrise Balanced eREIT II, LLC are real estate investment trust programs (the "eREITs"). The eREITs use a typical real estate investment trust ("REIT") structure similar to other publicly offered REITs, but are only available to investors via the internet on the Fundrise Platform. "eREIT<sup>®</sup>" is our registered trademark.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Fundrise Equity REIT, LLC, Fundrise Growth eREIT II, LLC, Fundrise Growth eREIT III, LLC, and Fundrise Growth eREIT VII, LLC pursue a strategy focused on long-term capital appreciation with a focus primarily on commercial real estate, including multifamily and build-for-rent properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Fundrise West Coast Opportunistic REIT, LLC, Fundrise East Coast Opportunistic REIT, LLC, and Fundrise Midland Opportunistic REIT, LLC pursue a balanced strategy of acquiring both debt and equity investments primarily within the geographic regions reflected in each eREIT's name. These eREITs focus on multifamily, industrial, creative office properties, and development projects.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Fundrise Development eREIT, LLC, focuses on renovation and new construction by investing directly in the development of primarily single family, multifamily, commercial, and mixed-use properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Fundrise Balanced eREIT II, LLC focuses on newly built multifamily properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Opportunity Fund, LP and Fundrise Opportunity Zone OP, LLC (collectively referred to as the "Opportunity Fund" or the "oFund"), make up a tax-advantaged real estate investment fund program offered under Regulation D ("Regulation D") of the Securities Act. The oFund focuses on high-quality real estate properties located in qualified opportunity zones, as designated under the Internal Revenue Code of 1986, as amended (the "Code"), and is invested in mixed-use development and creative office properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Opportunistic Credit Fund, LLC and Fundrise Opportunistic Credit Fund II, LLC (collectively, the "Credit Funds") are Delaware limited liability companies offered under Regulation D, that are offered through the Fundrise Platform. The Credit Funds focus on private credit investments such as preferred equity positions and asset backed securities primarily in the multifamily and single-family rental markets.

On October 24, 2025, Rise made an initial investment of $5,000 in Fundrise eREIT, LLC ("Fundrise eREIT"), a newly formed entity. The Registration Statement on Form S-4, which registered the common shares of Fundrise eREIT that were issued in connection with the mergers (the "Mergers") of certain of our existing eREITs listed below (collectively, the "Fundrise Merger Entities") with and into Fundrise eREIT, was declared effective by the SEC on April 24, 2026. The Mergers were completed on April 29, 2026. Refer to *<u>[Note 17](#i010073027201481f91c7f293a54ba05a_82)</u>*, *Subsequent Events* for more information on the Mergers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Development eREIT, LLC;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Equity REIT, LLC;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise East Coast Opportunistic REIT, LLC;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Growth eREIT II, LLC;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Growth eREIT III, LLC;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Midland Opportunistic REIT, LLC; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise West Coast Opportunistic REIT, LLC.

The eREITs, oFund, Credit Funds, Flagship Fund, Income Interval Fund and Innovation Fund are referred to, individually or collectively as the context requires, as the "Sponsored Programs," or the "Investment Products."

In connection with the closing of the Mergers, Fundrise eREIT entered into a real estate services agreement with Fundrise Real Estate, pursuant to which Fundrise Real Estate will be entitled to receive fees and expense reimbursements for services relating to the investment in and management of Fundrise eREIT's assets, similar to Fundrise Real Estate's arrangements with other Sponsored Programs.

**2. Summary of Significant Accounting Policies**

***Basis of Presentation***

The accompanying unaudited condensed consolidated financial statements of the Company are prepared on the accrual basis of accounting and conform to accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial reporting. Accordingly, certain information and note disclosures normally included in the financial statements prepared under U.S. GAAP have been condensed or omitted.

All adjustments considered necessary for a fair presentation of the Company's financial position, results of operations and cash flows have been included and are of a normal and recurring nature. Interim results are not necessarily indicative of operating results for any other interim period or for the entire year. The condensed consolidated balance sheet as of December 31, 2025 and certain related disclosures are derived from the Company's audited consolidated financial statements filed with the Form 10-K. These condensed consolidated financial statements should be read in conjunction with the Company's consolidated financial statements and notes thereto included in the Form 10-K. The condensed consolidated financial statements as of March 31, 2026 and for the three months ended March 31, 2026 and March 31, 2025, respectively, and certain related disclosures are unaudited and may not include year-end adjustments to make those consolidated financial statements comparable to audited results. Additionally, the significant accounting policies used in the preparation of these condensed consolidated financial statements are disclosed in the notes to the audited consolidated financial statements included in the Form 10-K. Other than as noted below, the significant accounting policies have not changed significantly.

***Principles of Consolidation***

The Company consolidates entities when we own, directly or indirectly, a majority interest in the entity or are otherwise able to control the entity. We consolidate variable interest entities ("VIEs") in accordance with the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 810, *Consolidation*, if we are the primary beneficiary of the VIE as determined by our power to direct the VIE's activities and the obligation to absorb its losses or the right to receive its benefits, which are potentially significant to the VIE. A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the

------

expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights.

As of March 31, 2026, the Company consolidated Moat and other wholly-owned entities as it was determined that Rise, together with its subsidiaries, is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. The Company's other disclosures regarding VIEs are discussed in *<u>[Note 14,](#i010073027201481f91c7f293a54ba05a_73)</u> Variable Interest Entities.*

***Estimates***

The preparation of the condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates.

***Change in Previous Estimate - Internal Use Software***

The Company capitalizes qualifying payroll and payroll-related costs incurred during the application development stage of internal-use software projects in accordance with ASC 350-40. Costs incurred during the preliminary project stage and post-implementation operation stage are expensed as incurred. Costs associated with upgrades and enhancements are capitalized only if such efforts will result in additional functionality. Capitalized costs are amortized on a straight-line basis over the estimated useful life of the related module, which the Company has historically estimated at four years. During the three months ended March 31, 2026, the Company revised the estimated useful life of an AI-related software module. See *<u>[Note 7](#i010073027201481f91c7f293a54ba05a_52)</u>, Property, Software and Equipment, net* for further detail.

***Reclassification of Current Period Non-controlling Interests***

During the first quarter of 2026, a misstatement was identified in the accounting for certain partnership interests in Moat, which resulted in a reclassification from Accumulated deficit to Non-controlling interests in the consolidated entity. The reclassification had no impact on total equity. The Company evaluated the error in accordance with SEC Staff Accounting Bulletin ("SAB") No. 99 and SAB No. 108 and concluded that the error was not material to any previously issued financial statements or the current financial statements. In accordance with FASB ASC 250, *Accounting Changes and Error Corrections* ("ASC 250"), the Company revised the error in the current period presented herein. The reclassification resulted in an increase in Accumulated deficit and an increase in Non-controlling interests in the consolidated entity of $1.3 million in the Company's Condensed Consolidated Balance Sheets and Statements of Changes in Convertible Preferred Stock, Stockholders' Equity and Non-Controlling Interest as of March 31, 2026. The reclassification had no impact on operating income, net income, earnings per share, consolidated assets, liabilities, total equity, or cash flows.

------

***Revision of Prior Period Financial Statements***

During the preparation of the Company's financial statements for the year ended December 31, 2025, the Company identified an immaterial error related to reimbursements of certain operating expenses of Sponsored Programs, primarily arising from an expense limitation agreement. These reimbursements were previously presented within operating expenses in the condensed consolidated statements of operations. The Company concluded that these reimbursements represent consideration payable to a customer under ASC 606 and should have been presented as a reduction of revenue.

The Company evaluated the error in accordance with SEC SAB No. 99 and SAB No. 108 and concluded that the error was not material to any previously issued financial statements. In accordance with ASC 250, we corrected this error by retrospectively revising the quarterly condensed consolidated financial statements for the three months ended March 31, 2025.

The error did not affect the timing or measurement of asset management fee revenue under the Company's investment management agreements. Asset management fees were recognized in the appropriate reporting periods and collected in full, and the revision made did not change the Company's total gross cash receipts or contractual fee arrangements with customers. The revision reflects a reclassification within the condensed consolidated statements of operations from operating expenses to a reduction of revenue, resulting in a net presentation of previously reported gross amounts, and had no impact on operating income, net income, earnings per share, consolidated assets, liabilities, equity, or cash flows. The revision relates solely to presentation within the condensed consolidated statement of operations. The following table reflects the impacts of the revision to the previously filed, unaudited financial statements for the three months ended March 31, 2025 (in thousands):

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| | **As Reported** | **Adjustment** | **As Revised** |
| **Revenue** | **$&nbsp;&nbsp;&nbsp;&nbsp;13415&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;(1460)** | **$&nbsp;&nbsp;&nbsp;&nbsp;11955&nbsp;&nbsp;&nbsp;&nbsp;** |
| **Costs and expenses** | | | |
| Marketing | &nbsp;&nbsp;&nbsp;&nbsp;3676&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(1460) | &nbsp;&nbsp;&nbsp;&nbsp;2216&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total costs and expenses** | **&nbsp;&nbsp;&nbsp;&nbsp;20393&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;(1460)** | **&nbsp;&nbsp;&nbsp;&nbsp;18933&nbsp;&nbsp;&nbsp;&nbsp;** |

---

***Concentrations of Credit Risk***

*Cash & Cash Equivalents*

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. To mitigate the risk of concentration associated with cash and cash equivalents, as well as restricted cash, funds are held with creditworthy institutions and, at certain times, temporarily swept into insured programs overnight to reduce single firm concentration risk. Cash may at times exceed the Federal Deposit Insurance Corporation deposit insurance limit of $250,000 per institution. To date, the Company has not experienced any material losses with respect to cash and cash equivalents.

*Due from Affiliates*

Receivables due from affiliates consist primarily of investment management fees and real estate fees due to us from the Sponsored Programs and investments of the Sponsored Programs which are paid to the Company on a quarterly or monthly basis, as applicable, from each Sponsored Program that it manages and investments of the Sponsored Programs, as applicable. These receivables are generally short term and settle within 30 to 90 days. We evaluate the collectability of the balances based on historical experience, current conditions, and reasonable and

------

supportable forecasts. The Company has not previously experienced a default related to these receivables. Due to the short-term nature of the receivables and lack of historical losses, we do not have an expectation of credit losses related to these receivables.

*Notes Receivable*

Notes receivable consist of notes due from a related party, as further described in *<u>[Note 15](#i010073027201481f91c7f293a54ba05a_76)</u>, Related Party Transactions.* We evaluate the collectability of the balances based on historical experience, current conditions, and reasonable and supportable forecasts. The Company has not previously experienced a default related to any of these notes issued. Due to the short-term nature of the receivable and lack of historical losses, we do not have an expectation of credit losses related to the notes receivable.

***Recent Accounting Pronouncements***

In December 2023, the FASB issued ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*. The ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as reconciling items that meet a quantitative threshold. Further, the ASU requires additional disclosures on income tax expense and taxes paid, net of refunds received, by jurisdiction. The new standard is effective for public business entities for annual periods beginning after December 15, 2024 (and emerging growth companies for annual periods beginning after December 15, 2025) on a prospective basis with the option to apply it retrospectively. Early adoption is permitted. The adoption of this guidance will result in the Company being required to include enhanced income tax related disclosures. The Company will adopt this guidance in its annual report for the fiscal year ending December 31, 2026. The guidance is not expected to have a material impact on the Company's consolidated financial statements, as the guidance only affects disclosure.

In November 2024, the FASB issued ASU 2024-03, *Income Statement* — *Reporting Comprehensive Income* — *Expense Disaggregation Disclosures (Subtopic 220-40),* which requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The new guidance is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application and early adoption is permitted. The Company is in the process of evaluating the potential impact of ASU 2024-03 on its consolidated financial statements and related disclosures.

In July 2025, the FASB issued ASU 2025-05, *Financial Instruments-Credit Losses* (Topic 326) — *Measurement of Credit Losses for Accounts Receivable and Contract Assets*. The amendments in this ASU provide (1) guidance on measuring expected credit losses using a probabilistic method and (2) a practical expedient for all entities that simplifies the estimation of expected credit losses for current trade accounts receivable and contract assets arising from revenue transactions. The ASU is effective for public business entities for fiscal years beginning after December 15, 2025, including interim periods within those fiscal years. The Company adopted ASU 2025-05 on January 1, 2026, including the practical expedient, and the adoption did not have a material impact on the Company's consolidated financial statements.

In September 2025, the FASB issued ASU 2025-06, *Intangibles* — *Goodwill and Other* — *Internal-Use Software (Subtopic 350-40)* which amends certain aspects of the accounting for and disclosure of internally developed software costs. The new guidance is effective for annual reporting periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Entities may apply the guidance prospectively, retrospectively, or via a modified prospective transition method. The Company is in the process of evaluating the potential impact of ASU 2025-06 on its financial statements and related disclosures.

------

***Emerging Growth Company***

The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), until the earlier of (a) the last day of the fiscal year (i) following the fifth anniversary of the date of an initial public offering pursuant to an effective registration statement under the Securities Act, (ii) in which we have total annual gross revenue of at least $1.235 billion, or (iii) in which we are deemed to be a large accelerated filer, which means the market value of our shares that is held by non-affiliates exceeds $700 million as of the date of our most recently completed second fiscal quarter, and (b) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. For so long as we remain an "emerging growth company" we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not "emerging growth companies" including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act. We cannot predict if investors will find our shares less attractive because we may rely on some or all of these exemptions.

In addition, Section 107 of the JOBS Act also provides that an "emerging growth company" can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an "emerging growth company" can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We will take advantage of the extended transition period for complying with new or revised accounting standards, which may make it more difficult for investors and securities analysts to evaluate us since our financial statements may not be comparable to companies that comply with public company effective dates.

**3. Net Loss Per Share and Net Loss Attributable to Common Stockholders**

The following table presents the calculation of basic and diluted net loss per share attributable to Rise Companies Corp. Class A, Class B, and Class F common stockholders (*in thousands, except share and per share data*):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Numerator: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $&nbsp;&nbsp;&nbsp;&nbsp;(3955) | $&nbsp;&nbsp;&nbsp;&nbsp;(4241) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: net income attributable to noncontrolling interest | &nbsp;&nbsp;&nbsp;&nbsp;129&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;162&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss attributable to common stockholders | $&nbsp;&nbsp;&nbsp;&nbsp;(4084) | $&nbsp;&nbsp;&nbsp;&nbsp;(4403) |
| Denominator: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding – basic and diluted | &nbsp;&nbsp;&nbsp;&nbsp;32404261&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;32546024&nbsp;&nbsp;&nbsp;&nbsp; |
| **Net loss per share attributable to common stockholders - basic and diluted**  | **$&nbsp;&nbsp;&nbsp;&nbsp;(0.13)** | **$&nbsp;&nbsp;&nbsp;&nbsp;(0.14)** |

---

The following potential common shares were excluded from the calculation of diluted net loss per share attributable to Rise Companies Corp. Class A, Class B, and Class F common stockholders because their effect would

------

have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Redeemable convertible preferred stock | &nbsp;&nbsp;&nbsp;&nbsp;11865046&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;11865046&nbsp;&nbsp;&nbsp;&nbsp; |
| Restricted stock units | &nbsp;&nbsp;&nbsp;&nbsp;9320642&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;8968830&nbsp;&nbsp;&nbsp;&nbsp; |
| Performance stock units | &nbsp;&nbsp;&nbsp;&nbsp;3018867&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;3018867&nbsp;&nbsp;&nbsp;&nbsp; |
| Restricted stock options | &nbsp;&nbsp;&nbsp;&nbsp;6500&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;6500&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total anti-dilutive securities**  | **&nbsp;&nbsp;&nbsp;&nbsp;24211055&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;23859243&nbsp;&nbsp;&nbsp;&nbsp;** |

---

**4. Revenue**

The following table presents the Company's net revenue disaggregated by category (in thousands):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| **Revenue:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment management and platform advisory, net <sup>(1)</sup> | $&nbsp;&nbsp;&nbsp;&nbsp;9632&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;6363&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate operating platform <sup>(2)</sup> | &nbsp;&nbsp;&nbsp;&nbsp;4502&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;4644&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate management | &nbsp;&nbsp;&nbsp;&nbsp;3395&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;948&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total revenue** | **$&nbsp;&nbsp;&nbsp;&nbsp;17529&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;11955&nbsp;&nbsp;&nbsp;&nbsp;** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Investment management and platform advisory, net is presented net of operating expense reimbursements to the Innovation Fund pursuant to the Expense Limitation Agreement of $1.5 million for the three months ended March 31, 2025 and includes recoupments from the Innovation Fund of $0.4 million for the three months ended March 31, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Real estate operating platform includes loan servicing fees, which are accounted for under FASB ASC 860, *Transfers and Servicing*. Loan servicing fees were $0.4 million and $0.3 million for the three months ended March 31, 2026 and 2025, respectively. No servicing asset or liability was identified in relation to these services. For more information on loan servicing fees, refer to *Note 2, Summary of Significant Accounting Policies—Revenue Recognition* of the Company's annual consolidated financial statements, which are included in the Form 10-K.

**5. Fair Value of Financial Instruments**

We are required to disclose an estimate of fair value of our financial instruments for which it is practicable to estimate the value. U.S. GAAP defines the fair value as the price that the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. For certain of our financial instruments, fair values are not readily available since there are no active trading markets as characterized by current exchanges by willing parties.

We determine the fair value of certain investments in accordance with the fair value hierarchy that requires an entity to maximize the use of observable inputs. The fair value hierarchy includes the following three levels based on the objectivity of the inputs, which were used for categorizing the assets or liabilities for which fair value is being measured and reported:

Level 1 – Quoted market prices in active markets for identical assets or liabilities.

------

Level 2 – Significant other observable inputs (e.g., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs).

Level 3 – Valuation generated from model-based techniques that use inputs that are significant and unobservable in the market. These unobservable assumptions reflect estimates of inputs that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow methodologies or similar techniques, which incorporate management's own estimates of assumptions that market participants would use in pricing the instrument or valuations that require significant management judgment or estimation.

As of March 31, 2026 and December 31, 2025, the Company's significant financial instruments are classified as Level 1 and consist of cash and cash equivalents and notes receivable. For all instruments in both periods, the carrying amount of the Company's financial instruments approximates their fair values due to their short-term nature.

Refer to *<u>[Note 10](#i010073027201481f91c7f293a54ba05a_61)</u>, Stock-Based Compensation and Other Employee Benefits*, for more information on the fair value inputs used to calculate the grant date fair values of the Company's stock-based awards.

**6. Leases**

On January 8, 2019, the Company entered into a ten-year non-cancelable operating lease agreement, expiring on August 31, 2030, for office space located at 11 Dupont Circle NW, Washington, DC 20036. The lease includes one option to renew, but the renewal is not deemed to be reasonably assured as of March 31, 2026. Our lease agreement does not contain any material residual value guarantees or material restrictive covenants.

Operating lease expense was $0.2 million for the three months ended March 31, 2026 and 2025.

As of March 31, 2026, our lease had a remaining lease term of 4.4 years and a discount rate of 7.5%. Future lease payments as of March 31, 2026 were as follows (*in thousands*):

---

| | |
|:---|:---|
| | **Operating**<br> **Leases** |
| 2026 | $&nbsp;&nbsp;&nbsp;&nbsp;818&nbsp;&nbsp;&nbsp;&nbsp; |
| 2027 | &nbsp;&nbsp;&nbsp;&nbsp;1113&nbsp;&nbsp;&nbsp;&nbsp; |
| 2028 | &nbsp;&nbsp;&nbsp;&nbsp;1140&nbsp;&nbsp;&nbsp;&nbsp; |
| 2029 | &nbsp;&nbsp;&nbsp;&nbsp;1169&nbsp;&nbsp;&nbsp;&nbsp; |
| 2030 | &nbsp;&nbsp;&nbsp;&nbsp;795&nbsp;&nbsp;&nbsp;&nbsp; |
| Total future lease payments | &nbsp;&nbsp;&nbsp;&nbsp;5035&nbsp;&nbsp;&nbsp;&nbsp; |
| Less: Imputed interest | &nbsp;&nbsp;&nbsp;&nbsp;746&nbsp;&nbsp;&nbsp;&nbsp; |
| **Present value of lease liabilities**  | **$&nbsp;&nbsp;&nbsp;&nbsp;4289&nbsp;&nbsp;&nbsp;&nbsp;** |
| Lease liabilities, current | &nbsp;&nbsp;&nbsp;&nbsp;1056&nbsp;&nbsp;&nbsp;&nbsp; |
| Lease liabilities, non-current | &nbsp;&nbsp;&nbsp;&nbsp;3233&nbsp;&nbsp;&nbsp;&nbsp; |
| **Present value of lease liabilities**  | **$&nbsp;&nbsp;&nbsp;&nbsp;4289&nbsp;&nbsp;&nbsp;&nbsp;** |

---

------

Other information related to our lease for the three months ended March 31, 2026 and 2025 is as follows (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| Operating cash flows | &nbsp;&nbsp;&nbsp;&nbsp;267&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;261&nbsp;&nbsp;&nbsp;&nbsp; |

---

**7. Property, Software and Equipment, net**

Property, software and equipment, net, consist of the following (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Internal-use software | $&nbsp;&nbsp;&nbsp;&nbsp;67365&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;67365&nbsp;&nbsp;&nbsp;&nbsp; |
| Leasehold Improvements | &nbsp;&nbsp;&nbsp;&nbsp;1668&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;1668&nbsp;&nbsp;&nbsp;&nbsp; |
| Computer equipment | &nbsp;&nbsp;&nbsp;&nbsp;619&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;671&nbsp;&nbsp;&nbsp;&nbsp; |
| Furniture and fixtures | &nbsp;&nbsp;&nbsp;&nbsp;240&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;240&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Total property, software and equipment | &nbsp;&nbsp;&nbsp;&nbsp;69892&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;69944&nbsp;&nbsp;&nbsp;&nbsp; |
| Less: accumulated amortization and depreciation | &nbsp;&nbsp;&nbsp;&nbsp;(45410) | &nbsp;&nbsp;&nbsp;&nbsp;(41161) |
| **Total property, software and equipment, net**  | **$&nbsp;&nbsp;&nbsp;&nbsp;24482&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;28783&nbsp;&nbsp;&nbsp;&nbsp;** |

---

Amortization and depreciation expense on property, software and equipment was approximately $4.3 million and $3.0 million for the three months ended March 31, 2026 and 2025, respectively. Included in these amounts were the amortization of capitalized internal-use software costs of approximately $4.2 million and $2.9 million for the three months ended March 31, 2026 and 2025, respectively.

There were no write-offs of internal-use software or resulting impairment losses recorded for the three months ended March 31, 2026 and 2025.

***Revision of Useful Life***

During the three months ended March 31, 2026, the Company revised the estimated useful life of an AI-related internal-use software module from four years to one year, resulting in a revised remaining amortization period ending September 2026. This revision reflects management's conclusion that the expected period of economic benefit of the in-service module is shorter than originally estimated due to changes in the product roadmap, including planned near-term development efforts that are expected to substantially replace the existing module earlier than originally anticipated. The software remains in active use through the transition period.

This change in estimate has been reflected prospectively beginning in the first quarter of 2026 in accordance with FASB ASC 250. The effect of this change was to increase amortization expense by approximately $0.7 million for the three months ended March 31, 2026. The remaining net book value of approximately $1.8 million as of March 31, 2026 will be amortized through September 2026, resulting in a total increase in 2026 depreciation and amortization expense within the consolidated statement of operations of $1.9 million. This change will reduce depreciation and amortization expense for the years 2027 through 2029 by the same amount.

------

**8. Loan Payable**

***PPP Loan Payable***

On April 20, 2020, the Company received a Paycheck Protection Program loan (the "PPP Loan") from Citizens Bank under the Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") in the principal amount of $2.8 million, bearing interest at a fixed rate of 1% per annum. The loan's initial maturity date of April 19, 2022 was extended to April 19, 2025.

In July 2021, the Company applied for forgiveness of the PPP Loan. In January 2025, the Company was notified that $2.3 million of the loan principal and related accrued interest was forgiven. The Company recorded a gain from debt extinguishment with respect to such loan forgiveness in its condensed consolidated statement of operations for the three months ended March 31, 2025. The remaining principal outstanding was paid during the three months ended March 31, 2025.

**9. Supplemental Financial Statement Information**

***Accrued expenses***

Accrued expenses consist of the following (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Accrued compensation and employee benefits | $&nbsp;&nbsp;&nbsp;&nbsp;2077&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;7284&nbsp;&nbsp;&nbsp;&nbsp; |
| Accrued audit and tax expenses | &nbsp;&nbsp;&nbsp;&nbsp;351&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;241&nbsp;&nbsp;&nbsp;&nbsp; |
| Accrued legal expenses | &nbsp;&nbsp;&nbsp;&nbsp;281&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |
| Other accrued expenses | &nbsp;&nbsp;&nbsp;&nbsp;204&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;220&nbsp;&nbsp;&nbsp;&nbsp; |
| Accrued deferred costs of Sponsored Programs | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;24&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total**  | **$&nbsp;&nbsp;&nbsp;&nbsp;2913&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;7769&nbsp;&nbsp;&nbsp;&nbsp;** |

---

***Other current liabilities***

Other current liabilities consist of the following (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Employee benefit contributions payable | $&nbsp;&nbsp;&nbsp;&nbsp;1135&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;75&nbsp;&nbsp;&nbsp;&nbsp; |
| Deal-related deposits payable | &nbsp;&nbsp;&nbsp;&nbsp;392&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;512&nbsp;&nbsp;&nbsp;&nbsp; |
| Medical claims payable | &nbsp;&nbsp;&nbsp;&nbsp;30&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;861&nbsp;&nbsp;&nbsp;&nbsp; |
| Other current liabilities | &nbsp;&nbsp;&nbsp;&nbsp;315&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;3&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total**  | **$&nbsp;&nbsp;&nbsp;&nbsp;1872&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;1451&nbsp;&nbsp;&nbsp;&nbsp;** |

---

**10. Stock-Based Compensation and Other Employee Benefits**

***Stock-Based Compensation***

Under our 2014 Stock Option and Grant Plan, as amended (the "Plan"), we may grant unrestricted stock grants, restricted stock grants ("RSGs"), restricted stock units ("RSUs"), restricted stock options ("RSOs"), performance stock units ("PSUs"), and other types of awards as specified in the plan to provide shares of Common Stock to employees, executives, directors, and consultants, subject to applicable vesting. A total of 20,100,000 shares of Class A Common Stock have been authorized for issuance under the Plan as of March 31, 2026 and December 31, 2025. The Company has issued RSGs, RSUs, RSOs, and PSUs as of March 31, 2026.

------

The Company issued no RSGs and no shares were forfeited for the three months ended March 31, 2026 and 2025. The Company issued no RSOs for the three months ended March 31, 2026 and 2025. During the three months ended March 31, 2026 and 2025, zero and 2,500 outstanding RSOs were forfeited, respectively. The Company recognized $0 of stock-based compensation expense related to RSGs and RSOs during the three months ended March 31, 2026 and 2025, respectively. As of both March 31, 2026 and December 31, 2025, there were no remaining unvested shares and no unrecognized stock-based compensation expense related to RSGs or RSOs. During the three months ended March 31, 2025, one former employee exercised 2,500 shares of outstanding RSOs at an exercise price of $5.25 per share. As of March 31, 2026, 6,500 RSOs remained outstanding and unexercised.

There was no net income tax benefit recognized relating to stock-based compensation expense and no tax benefits have been realized from RSGs or RSOs due to the full valuation allowance during the three months ended March 31, 2026 and 2025.

During the three months ended March 31, 2026 and 2025, the Company issued RSUs and PSUs with various vesting conditions, as further described below. All of the RSUs and PSUs contain performance-based vesting conditions, none of which have been deemed probable as of March 31, 2026. Thus, no stock compensation expense for these awards has been recognized to-date. In the period in which a qualifying event is probable, the Company will record a cumulative one-time stock-based compensation expense determined using the grant-date fair values. Stock-based compensation related to remaining time-based service after the qualifying event will be recorded over the remaining requisite service period using an accelerated attribution method. The total unrecognized share-based compensation expense related to the RSUs was $130.6 million as of March 31, 2026. Of this amount, $94.0 million relates to awards for which the time-based vesting condition has been satisfied or partially satisfied, while $36.6 million relates to awards for which the time-based vesting condition had not yet been satisfied. The total unrecognized share-based compensation expense related to the PSUs was approximately $38.6 million as of March 31, 2026.

*Restricted Stock Units*

RSUs issued through March 31, 2026 and December 31, 2025 generally follow a time-based vesting schedule whereby 25% of the award vests twelve months from the vesting commencement date, and 6.25% vest quarterly thereafter, provided the grantee remains continuously employed by the Company through each vesting date. The Board will also occasionally grant, at its discretion, RSUs that have no time-based vesting requirements and are only subject to the performance-based vesting requirement described below. In addition, the Board retains the authority to grant future shares with different terms. The RSUs are also subject to performance-based vesting, and will only satisfy this requirement on the first of the following to occur: (i) immediately prior to a Company sale event or (ii) the Company's Initial Public Offering. RSUs granted but not vested expire seven years after the grant date.

The grant-date fair value of RSUs is estimated based on the fair value of our Common Stock on the date of grant. The Company considers numerous objective and subjective factors to determine the fair value of our Common Stock, including: sales of our Common Stock to third-party investors in arm's-length transactions, our operating and financial performance, the valuation of comparable companies, the lack of marketability, and general and industry specific economic outlook, amongst other factors.

------

The following table summarizes the activity related to our RSUs for the three months ended March 31, 2026:

---

| | | |
|:---|:---|:---|
| | **Number of RSUs** | **Weighted-average grant date fair value** |
| Unvested restricted stock units at December 31, 2025 | &nbsp;&nbsp;&nbsp;&nbsp;8509946&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;13.73&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | &nbsp;&nbsp;&nbsp;&nbsp;932618&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;15.90&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited | &nbsp;&nbsp;&nbsp;&nbsp;(44422) | &nbsp;&nbsp;&nbsp;&nbsp;12.35&nbsp;&nbsp;&nbsp;&nbsp; |
| &nbsp;&nbsp;&nbsp;&nbsp;Expired | &nbsp;&nbsp;&nbsp;&nbsp;(77500) | &nbsp;&nbsp;&nbsp;&nbsp;6.90&nbsp;&nbsp;&nbsp;&nbsp; |
| Unvested restricted stock units at March 31, 2026 | &nbsp;&nbsp;&nbsp;&nbsp;9320642&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;14.01&nbsp;&nbsp;&nbsp;&nbsp; |

---

*Performance Stock Units*

In January 2025, the Company granted 3,018,867 PSUs to certain Company executives with a grant date fair value of $12.80 per share. The PSUs will vest upon the occurrence of the first of the following: (i) immediately prior to a sale event that values the company at a certain target price or more (the "Target Price"), (ii) the Company's Initial Public Offering at a valuation of at least the Target Price, or (iii) the Company being valued on a national securities exchange at the Target Price. Each of the three vesting conditions previously listed include both a performance condition and a market condition as defined under FASB ASC 718, *Compensation - Stock Compensation*. All vesting conditions also require continued service.

Due to the market conditions included within each vesting scenario described above, the Company estimated the grant date fair value of the PSUs using a Monte Carlo option pricing model which requires Level 3 fair value inputs. The Company considers numerous objective and subjective factors to determine the fair value of our Common Stock, including: sales of our Common Stock to third-party investors in arm's-length transactions, our operating and financial performance, the valuation of comparable companies, the lack of marketability, and general and industry specific economic outlook, amongst other factors. Volatility used in the models is derived from the historical volatility of certain publicly traded companies. The risk-free rate included in the models was calculated using the U.S. Treasury daily yield curve and is continuously compounded in the models. The key assumptions used to calculate the grant date fair value of the PSUs were as follows:

---

| | |
|:---|:---|
| Fair Value of Common Stock | $&nbsp;&nbsp;&nbsp;&nbsp;15.90&nbsp;&nbsp;&nbsp;&nbsp; |
| Expected Volatility | &nbsp;&nbsp;&nbsp;&nbsp;59&nbsp;&nbsp;&nbsp;&nbsp;% |
| Expected Dividends | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp;% |
| Risk-Free Rate | &nbsp;&nbsp;&nbsp;&nbsp;4.30&nbsp;&nbsp;&nbsp;&nbsp;% |
| Expected term (in years) | 3.98 |

---

***401(k) Plan***

Effective January 1, 2020, the Company established an employer-sponsored employee retirement 401(k) plan. All of our employees qualify to participate under the plan criteria. Participants may elect to contribute any portion of their annual compensation up to the maximum limit imposed by federal tax law. For the periods presented, the Company made non-elective contributions to each employee equal to 3% of their compensation. For the three months ended March 31, 2026 and 2025, contributions totaled approximately $0.3 million and $0.4 million, respectively.

------

**11. Income Tax**

Our income tax benefit (expense) was $— for the three months ended March 31, 2026 and 2025.

The Company recognizes a valuation allowance which reduces the deferred tax assets to the amount we believe these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize our deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. As of March 31, 2026 and December 31, 2025, the value of the deferred tax asset, net of the valuation allowance, was $0.

The Company's effective tax rate for both 2026 and 2025 was 0% and differs from the statutory rate of 21%, primarily as a result of our valuation allowance in both years, which fully offsets net deferred tax assets.

***Tax Legislation Changes***

On July 4, 2025, the One Big Beautiful Bill Act (the "OBBBA") was signed into law, which makes permanent certain tax provisions enacted in 2017 as part of the Tax Cuts and Jobs Act, such as 100% bonus depreciation, and also restores or modifies other business tax rules, including domestic research or experimental cost expensing and the business interest expense limitation. In addition, the OBBBA makes changes to certain U.S. corporate tax provisions, but many are generally not effective until 2026. The Company is currently evaluating the potential impacts of the OBBBA; however, it is not expected to have a material impact on the Company's condensed consolidated financial statements. As a result of the full valuation allowance as of March 31, 2026, the OBBBA did not have an impact on the condensed consolidated financial statements as of and for the period ended March 31, 2026. The impact of the OBBBA on future periods will depend on any related guidance issued by the U.S. Department of the Treasury and the Internal Revenue Service.

**12. Convertible Preferred Stock and Stockholders' Equity**

***Preferred Stock***

The outstanding shares of Series A convertible preferred stock are not mandatorily or otherwise redeemable. The sale of all, or substantially all, of the Company's assets, a consolidation or merger with another company, or a transfer of voting control in excess of fifty percent (50%) of the Company's voting power are all events which are deemed to be a liquidation and would trigger the payment of liquidation preferences under the Company's Certificate of Incorporation. The significant terms of outstanding Series A preferred shares are as follows:

*<u>Conversion</u>* – Each share of Series A is convertible, at the option of the holder, initially, into one share of Class A Common Stock (subject to adjustments for events of dilution). Each share of convertible preferred stock will automatically be converted upon: (i) the election of a majority of the outstanding shares of such series of preferred stock; or (ii) the consummation of an underwritten registered public offering with aggregate proceeds in excess of $35 million (a "Qualified Public Offering"). The Company's Certificate of Incorporation contains certain anti-dilution provisions, whereby if the Company issues additional shares of capital stock for an effective price lower than the conversion price for a series of preferred stock immediately prior to such issue, then the existing conversion price of such series of preferred stock will be reduced. The Company determined that while its convertible preferred stock contains certain anti-dilution features, the conversion feature embedded within its convertible preferred stock does not require bifurcation under the guidance of ASC 815, *Derivatives and Hedging Activities*.

------

*<u>Liquidation preference</u>* – Upon any liquidation, winding up or dissolution of the Company, whether voluntary or involuntary (a "Liquidation Event"), before any distribution or payment will be made to the holders of any Common Stock, the holders of convertible preferred stock will be entitled to receive, by reason of their ownership of such stock, an amount per share of Series A equal to $2.1872 (as adjusted for stock splits, recapitalizations and other similar events) plus all declared and unpaid dividends (the "Series A Preferred Liquidation Preference"). However, if, upon any such Liquidation Event, our assets are insufficient to make payment in full to all holders of convertible preferred stock of their respective liquidation preferences, then the entire balance of the Company's assets legally available for distribution will be distributed with equal priority between the preferred holders based upon the amount of each such holders' Series A Preferred Liquidation Preference. Any excess assets, after payment in full of the liquidation preferences to the convertible preferred stockholders, are then allocated to the holders of the Common Stock, pro-rata.

*<u>Dividends</u>* – If and when declared by the Board, the holders of Series A and Common Stock, on a pari passu basis, will be entitled to receive dividends. As of March 31, 2026 and December 31, 2025, we have not declared any dividends on preferred stock or Common Stock.

*<u>Voting rights</u>* – Generally, preferred stockholders have one (1) vote for each share of Common Stock that would be issuable upon conversion of preferred stock. Voting as a separate class, the Series A stockholders are entitled to elect one member of the Board. The holders of Common Stock, voting as a separate class, are entitled to elect two members of the Board. The remaining two members are elected by the preferred stockholders and common stockholders voting together as a single class on an as-if-converted to Common Stock basis. The Company has adopted a dual-class Common Stock structure, pursuant to which each share of Class A Common Stock will have one (1) vote per share and each share of Class F Common Stock will have ten (10) votes per share.

The Company has classified the Series A convertible preferred stock as mezzanine equity in accordance with FASB ASC 480, *Distinguishing Liabilities from Equity*, as the shares have certain redemption features within the liquidation preference upon a change of control that are not solely in control of the Company. The Series A convertible preferred stock is not currently redeemable because the deemed liquidation provision related to a change in control is considered a substantive condition that is contingent on an event and it is not currently probable that it will become redeemable. The carrying value of the Series A convertible preferred stock, which includes the proceeds received upon issuance, has not been adjusted to liquidation value since the securities are not currently redeemable or probable to become redeemable. Subsequent adjustments to increase the carrying value to the liquidation value will be made only if and when it becomes probable that a change in control or other deemed liquidation event will occur.

***Common Stock***

*Class A Common Stock*

As of March 31, 2026 and December 31, 2025, there were 2,891,359 shares issued and 2,458,394 shares outstanding. Holders of our Class A Common Stock are entitled to one (1) vote for each share held of record on all matters submitted to a vote of stockholders.

*Class F Common Stock*

In April of 2014, the Company issued a total of 10,000,000 shares of Class F Common Stock to Daniel Miller and to Benjamin Miller, with a par value of $0.0001 per share. Each share of the Class F Common Stock is entitled to ten (10) votes per share. As of March 31, 2026 and December 31, 2025, there were 10,000,000 shares of Class F Common Stock issued and outstanding.

------

*Class B Common Stock*

On January 19, 2017, the Board of the Company created a new class of Common Stock, to be designated as Class B Common Stock, with a par value of $0.0001 per share. As of March 31, 2026 and December 31, 2025, 38,000,000 shares have been authorized as Class B Common Stock. As of March 31, 2026 and December 31, 2025 respectively, there were 22,207,313 and 21,970,987 shares of Class B Common Stock issued and 20,056,589 and 19,826,469 shares outstanding. Except as required by applicable law, the holders of our Class B Common Stock are not entitled to vote on any matters submitted to a vote of stockholders.

***Investors' Rights Agreement***

In 2014 we entered into an Investors' Rights Agreement (the "IRA") with certain holders of our Class F Common Stock and Series A Preferred Stock, including persons who held more than 10% of any class of our outstanding capital stock, certain of our executive officers and directors and entities with which certain of our directors are affiliated. Pursuant to the IRA, the holders of certain shares of our Common Stock and preferred stock are entitled to certain registration rights, information rights, and preemptive rights.

***Right of First Refusal and Co-Sale Agreement***

In 2014, we entered into a Right of First Refusal and Co-Sale Agreement (the "Co-Sale Agreement") with certain holders of our Common Stock and preferred stock, including persons who hold more than 10% of our outstanding capital stock, certain of our executive officers and directors, and entities with which certain of our directors are affiliated. Pursuant to the Co-Sale Agreement, the holders of our preferred stock have rights of first refusal and co-sale with respect to certain transfers made by certain holders of our Common Stock.

***Voting Agreement***

In 2014 we entered into a Voting Agreement (the "Voting Agreement") with certain holders of our Class F Common Stock and Series A Preferred Stock, including persons who held more than 10% of any class of our outstanding capital stock, our executive officers and directors, and entities with which certain of our directors are affiliated. Pursuant to the Voting Agreement, the holders of certain shares of our Common Stock and preferred stock have agreed to vote their shares on certain matters, including with respect to the election of directors.

**13. Segment and Geographic Information**

The Company operates and manages its business as one reportable and operating segment, which comprises all of Rise Companies and its consolidated subsidiaries. The consolidated financial results of Rise Companies are reported to the chief operating decision maker (the "CODM"), who the Company determined is a committee of its Chief Executive Officer and Chief Operating Officer. To assess the performance of the Company and make decisions on future resource allocation and other key operating strategies, the CODM reviews net (loss) income as reported in the condensed consolidated statements of operations. Significant segment expenses within net (loss) income include cost of revenue, technology and product development, marketing, general, administrative and other, and depreciation and amortization which are each presented separately on the condensed consolidated statements of operations. Other segment expenses include income tax benefit (expense), which is presented separately on the condensed consolidated statements of operations. Refer to the condensed consolidated financial statements for other financial information regarding the Company's operating segment. The CODM does not review assets in evaluating the results of the Company's operating segment, and therefore such information is not presented.

------

The Investment Products earn various fees, as further described in *Note 2, Summary of Significant Accounting Policies*—*Revenue Recognition* of its annual consolidated financial statements, which are included in the Form 10-K. All of the Company's assets and operations are located in the United States.

**14. Variable Interest Entities**

Pursuant to GAAP consolidation guidance, the Company consolidates certain VIEs for which it is the primary beneficiary. As of March 31, 2026 and December 31, 2025, the Company consolidated Moat. Rise Companies acts as the General Partner of Moat through a wholly-owned subsidiary, holds a 2% ownership interest in Moat and has the ability to manage its assets. The Company does not provide performance guarantees and has no other financial obligation to provide funding to Moat. The assets of Moat may only be used to settle obligations of Moat. In addition, there is no recourse to the Company for Moat's liabilities.

The non-controlling interests ("NCI") are related to the limited partner holdings in Moat in which we have a controlling financial interest. In February 2026, Moat made an early equity distribution to its partners totaling $2.5 million, in anticipation of its contracted dissolution in the second quarter of 2026. NCI as of March 31, 2026 and December 31, 2025, respectively, were $11.3 million and $12.3 million. As of March 31, 2026 and December 31, 2025, the assets in the limited partnership were primarily cash and cash equivalents, notes receivable, and investments in the Sponsored Programs.

The Company holds variable interests in certain VIEs which are not consolidated, as it is determined that the Company is not the primary beneficiary, including its investments in the eREITs, oFund, and the Credit Funds as of March 31, 2026 and December 31, 2025. The Company's involvement with such entities is in the form of direct equity interests and fee arrangements. The maximum exposure to loss represents the loss of assets recognized by the Company relating to non-consolidated VIEs. The Company's maximum exposure to loss relating to non-consolidated VIEs were as follows (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Due from affiliates | $&nbsp;&nbsp;&nbsp;&nbsp;2622&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;2240&nbsp;&nbsp;&nbsp;&nbsp; |
| Investments in Sponsored Programs | &nbsp;&nbsp;&nbsp;&nbsp;942&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;959&nbsp;&nbsp;&nbsp;&nbsp; |
| Other current assets, net | &nbsp;&nbsp;&nbsp;&nbsp;14&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;16&nbsp;&nbsp;&nbsp;&nbsp; |
| Other assets, net | &nbsp;&nbsp;&nbsp;&nbsp;1846&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;1846&nbsp;&nbsp;&nbsp;&nbsp; |
| Maximum Exposure to Loss | **$&nbsp;&nbsp;&nbsp;&nbsp;5424&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;5061&nbsp;&nbsp;&nbsp;&nbsp;** |
| Amounts Due to Non-Consolidated VIEs | $&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |

---

------

**15. Related Party Transactions**

In addition to those disclosed elsewhere in the notes to the condensed consolidated financial statements, the following related party transactions are disclosed:

***Affiliate Receivables and Payables***

Due from affiliate receivables consist of the following (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Investment management and platform advisory receivables | $&nbsp;&nbsp;&nbsp;&nbsp;4625&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;4060&nbsp;&nbsp;&nbsp;&nbsp; |
| Real estate operating platform receivables | &nbsp;&nbsp;&nbsp;&nbsp;1452&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;1527&nbsp;&nbsp;&nbsp;&nbsp; |
| Real estate management receivables | &nbsp;&nbsp;&nbsp;&nbsp;4&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;48&nbsp;&nbsp;&nbsp;&nbsp; |
| Other receivables from affiliates <sup>(1)</sup> | &nbsp;&nbsp;&nbsp;&nbsp;2423&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;1302&nbsp;&nbsp;&nbsp;&nbsp; |
| **Total**  | **$&nbsp;&nbsp;&nbsp;&nbsp;8504&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;6937&nbsp;&nbsp;&nbsp;&nbsp;** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Other receivables from affiliates consist primarily of operating and other administrative costs incurred on behalf of the Sponsored Programs for which the Company is expecting reimbursement.

Deferred costs of the Sponsored Programs are approximately $1.8 million and are included in Other assets, net on the condensed consolidated balance sheets as of March 31, 2026 and December 31, 2025. Amounts due to affiliates are not material as of March 31, 2026 or December 31, 2025.

***Investments in Sponsored Programs by Company's Executives***

Many of the Company's executive officers and directors (including immediate family members) have opened investor accounts on the Fundrise Platform. All investments (and redemptions, where applicable) were made in the ordinary course of business and transacted on terms and conditions that were not more favorable than those obtained by third-party investors.

***Moat Investments, LP Promissory Notes***

National Lending, LLC ("National Lending") is a self-sustaining lending entity, financed by certain of the Sponsored Programs. Rise became the manager of National Lending effective June 18, 2025, but does not hold any equity interest in National Lending. Prior to this change, an independent manager managed National Lending under a management agreement at a market rate.

On October 1, 2024, Moat made a loan of $9.0 million to National Lending. The loan carried an annual interest rate of 5.25% and was set to mature on September 30, 2025. This loan was modified on September 15, 2025, resulting in the following changes to the loan: (i) the accrued interest was capitalized into the principal amount of the loan, resulting in an updated principal amount of $9.5 million, (ii) the term was extended through April 7, 2026, and (iii) the modified principal amount carries an annual interest rate of 5.25% as of the modification date.

On December 31, 2024, Moat made another loan of $3.5 million to National Lending. The loan carried an annual interest rate of 4.75% and was set to mature on December 31, 2025. This loan was modified on September 15, 2025, resulting in the following changes to the loan: (i) the accrued interest was capitalized into the principal amount of the loan, resulting in an updated principal amount of $3.6 million, (ii) the term was extended through April 7, 2026, and (iii) the modified principal amount carries an annual interest rate of 5.25% as of the modification date.

------

On February 17, 2026, National Lending paid down $2.5 million of the outstanding principal of the above loans. The remaining principal was repaid upon maturity*.*

For the periods presented, the balances for the outstanding loans from Moat are included in Notes receivable on the condensed consolidated balance sheets and the accrued interest on the notes is included in Other current assets, net on the condensed consolidated balance sheets.

***Moat Investments, LP Distribution***

In February 2026, Moat made an equity distribution to its partners totaling $2.5 million; Refer to *<u>[Note 14](#i010073027201481f91c7f293a54ba05a_73)</u>, Variable Interest Entities* for more information.

**16. Commitments and Contingencies**

***Liquidation Support Agreement – Fundrise Equity REIT, LLC***

To mitigate the effect of Fundrise Equity REIT, LLC's (one of our initial Sponsored Programs) lack of assets, revenue, and operating history, Fundrise Advisors agreed to make a payment to Fundrise Equity REIT, LLC of up to $500,000 if the distributions paid upon liquidation (together with any distributions made prior to liquidation) are less than a 20% average annual non-compounded return. This is a contingent liability that was reasonably possible but the amount of loss could not be reasonably estimated and therefore was not accrued as of March 31, 2026 or December 31, 2025, due to uncertainty around the Mergers. Refer to *<u>[Note 17](#i010073027201481f91c7f293a54ba05a_82)</u>, Subsequent Events* for more information. The following table details the amount of payment at varying levels of return (*in thousands*):

---

| | |
|:---|:---|
| **Average Annual Non-Compounded Return** | **Liquidation Support Payment** |
| 17.0% or less | $&nbsp;&nbsp;&nbsp;&nbsp;500&nbsp;&nbsp;&nbsp;&nbsp; |
| 17.1% to 18.0% | $&nbsp;&nbsp;&nbsp;&nbsp;400&nbsp;&nbsp;&nbsp;&nbsp; |
| 18.1% to 19.0% | $&nbsp;&nbsp;&nbsp;&nbsp;300&nbsp;&nbsp;&nbsp;&nbsp; |
| 19.1% to 19.9% | $&nbsp;&nbsp;&nbsp;&nbsp;200&nbsp;&nbsp;&nbsp;&nbsp; |
| 20.0% or greater | $&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |

---

***Legal Proceedings***

As of the date of these condensed consolidated financial statements, we are not currently named as a defendant in any active or pending material litigation. However, it is possible that the Company could become involved in various litigation matters arising in the ordinary course of our business. Although we are unable to predict with certainty the eventual outcome of any litigation, management is not aware of any litigation likely to occur that we currently assess as being significant to us.

**17. Subsequent Events**

Management has evaluated subsequent events for potential recognition or disclosure in these condensed consolidated financial statements through May 8, 2026, which was the date the condensed consolidated financial statements were available to be issued.

***Mergers***

On April 29, 2026, Fundrise eREIT and the Fundrise Merger Entities entered into an Agreement and Plan of Merger, and the Fundrise Merger Entities merged with and into Fundrise eREIT, a single surviving entity. As a

------

result of the Mergers, Fundrise eREIT commenced operations and was deconsolidated as the Company was determined to no longer be the primary beneficiary. No gain or loss was recognized upon deconsolidation.

***Liquidation Support Agreement – Fundrise Equity REIT, LLC***

As a result of the completion of the Mergers, Fundrise Equity REIT, LLC will complete a liquidation. As of the date of this filing, the Company estimated that the liquidation payment, as described in *<u>[Note 16](#i010073027201481f91c7f293a54ba05a_79)</u>, Commitments and Contingencies*, will be approximately $0.3 million.

***Moat Investments, LP Dissolution***

Pursuant to the terms of its partnership agreement, Moat, a consolidated subsidiary of the Company, initiated dissolution proceedings in the second quarter of 2026. The Company holds a 2% economic interest in Moat and consolidates the entity as its primary beneficiary. In April 2026, National Lending repaid its outstanding notes receivable to Moat (see *<u>[Note 15](#i010073027201481f91c7f293a54ba05a_76)</u>, Related Party Transactions)* and Moat distributed $10.7 million to a noncontrolling partner to process the dissolution.

As of the date of this filing, the Company does not expect the deconsolidation of Moat to result in a material gain or loss. The dissolution and deconsolidation are expected to be completed in the second quarter of 2026.

------

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

The following discussion of our financial condition and results of operations should be read in conjunction with the Condensed Consolidated Financial Statements and notes thereto appearing elsewhere in this Quarterly Report. The following discussion contains forward-looking statements. See "Statements Regarding Forward-Looking Information" within this Quarterly Report.

**Business**

Rise Companies is a Delaware corporation that was formed on March 10, 2014. Our office is located at 11 Dupont Circle NW, 9th Floor, Washington, D.C. 20036. Our telephone number is (202) 584-0550. Information regarding the Company is also available on our website at *<u>www.fundrise.com</u>*. The Company, together with its subsidiaries and affiliate organizations ("Fundrise"), combines modern financial technology and investment management to build the next generation of alternative asset management. Refer to *<u>[Note 1](#i010073027201481f91c7f293a54ba05a_34)</u>, Formation and Organization* in the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report for a description of our corporate structure and affiliated entities.

The Fundrise Platform has allowed us to build a differentiated business with what we believe is a significant competitive advantage and a robust, proprietary software infrastructure. We generate revenue from investment management and platform advisory fees, real estate operating platform fees, and real estate management fees, which are detailed in *<u>[Note 4](#i010073027201481f91c7f293a54ba05a_43)</u>, Revenue* in the Notes to our Condensed Consolidated Financial Statements included in this Quarterly Report.

We own and operate the Fundrise Platform, a leading web-based and mobile alternative asset investment platform. We use industry-specific expertise to evaluate, originate, service and manage investment opportunities through our fund management. We seek to develop alternative investment vehicles for external investors, for which we provide asset management services, typically under long-term management arrangements either through a contract with, or as the manager or general partner of, our Investment Products.

We limit our investment vehicle development and management services to asset classes where we have specific expertise. We believe this strategy enhances the return on investment we can achieve for our investment vehicles.

As of March 31, 2026, the Investment Products have total assets under management ("AUM") of $3.4 billion. As of March 31, 2026, the Fundrise Platform has over 402,000 active investor accounts and 2,411,000 active users.

**Recent Developments**

***RealAI***

In September 2025, we launched RealAI, a platform intended to provide AI-enabled insights related to real estate investing across the broader real estate market. RealAI is in the early stages of commercialization and did not generate material revenue for the year ended December 31, 2025 or the three months ended March 31, 2026. In early 2026, we publicly announced the platform and began making the product available to the general public. We expect to continue investing in the product's development and commercialization, and our results of operations could be impacted by the pace of user adoption and our ability to monetize the platform over time.

***Innovation Fund Listing***

On March 19, 2026, the Innovation Fund was listed on the New York Stock Exchange under the ticker "VCX" and converted from a closed-end tender offer fund into a listed closed-end fund. Following the listing and

------

conversion, revenue will continue to be based on the Innovation Fund's net asset value, which is subject to the Fund's underlying portfolio and investment performance.

**Results of the Business**

We are encouraged by both the performance of the alternative investments held by our Investment Products and by our own ability to navigate the evolving economic landscape. Despite ongoing challenges and macroeconomic headwinds such as persistent inflation, elevated interest rates, tariffs and volatility in real estate markets, our investments continue to demonstrate resilience.

As of March 31, 2026 and December 31, 2025, there was approximately $3.4 billion and $3.1 billion in equity AUM, respectively, across our Investment Products. The increase in equity AUM during the three months ended March 31, 2026 was driven primarily by growth and performance in the Fundrise Investment Products, including the Innovation Fund and the Flagship Fund. During the quarter, the Flagship Fund delivered a net return of approximately 10% for the quarter, driven in part by strategic investments in AI infrastructure and data centers. Current quarter performance occurred against a backdrop of heightened macroeconomic uncertainty stemming from the conflict in Iran, which contributed to rising interest rates and compressed real estate valuations across portions of our portfolio.

As of March 31, 2026, we have yet to generate any profits from our operations and are incurring net losses while we continue to invest in development and other initiatives to support the expansion of our business. Our results of operations in the beginning of 2026 reflect increased revenues as a result of increased AUM held by the Investment Products and increased real estate transaction activity. These gains were partially offset by (i) increased research and development expense driven by a reduction in engineering salaries being capitalized as certain development efforts did not qualify for capitalization, (ii) increased marketing expenses to support the VCX listing and other initiatives, and (iii) increased spending on third-party software and tools to support the launch of RealAI.

Refer to *<u>[Note 17](#i010073027201481f91c7f293a54ba05a_82)</u>, Subsequent Events* in the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report for more details on recent developments.

**Results of Operations**

***Revision of Prior Period Financial Statements***

As discussed in *<u>[Note 2](#i010073027201481f91c7f293a54ba05a_37)</u>, Summary of Significant Accounting Policies*, the Company identified an immaterial classification error related to reimbursements of certain operating expenses of Sponsored Programs, primarily arising from an expense limitation agreement. These reimbursements were previously presented within operating expenses in the condensed consolidated statements of operations. The Company concluded that these reimbursements represent consideration payable to a customer under ASC 606 and should therefore be presented as a reduction of revenue. Management determined the error was not material to any previously issued financial statements and corrected the error by retrospectively revising the quarterly Condensed Consolidated Financial Statements for the three months ended March 31, 2025.

The revision reflects a reclassification within the condensed consolidated statements of operations from operating expenses to a reduction of revenue, resulting in a net presentation of previously reported gross amounts, and has no impact on operating income, net income, earnings per share, assets, liabilities, equity, or cash flows.

------

***Three Months Ended March 31, 2026 compared to the Three Months Ended March 31, 2025***

For the three months ended March 31, 2026 and 2025, our results of operations are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Three Months Ended<br>March 31, 2026**<br>*(in thousands)* | **Three Months Ended<br>March 31, 2025**<br>*(in thousands)* | **% Change**<br>*(from 2025)* | **Explanation** |
| **Revenue** | | | | |
| Investment management and platform advisory, net | $&nbsp;&nbsp;&nbsp;&nbsp;9632&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;6363&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;51&nbsp;&nbsp;&nbsp;&nbsp;% | Investment management and platform advisory income, net increased period over period due to (i) higher asset management fees of approximately $1.7 million earned from increases in AUM, primarily driven by the Innovation Fund, and (ii) a net $1.9 million period-over-period impact related to operating expense reimbursements to the Innovation Fund ($1.5 million paid in Q1 2025 versus $0.4 million recouped in Q1 2026). |
| Real estate operating platform | &nbsp;&nbsp;&nbsp;&nbsp;4502&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;4644&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;-3&nbsp;&nbsp;&nbsp;&nbsp;% | Real estate operating platform income remained consistent due to relatively consistent underlying asset values period-over-period. |
| Real estate management | &nbsp;&nbsp;&nbsp;&nbsp;3395&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;948&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;258&nbsp;&nbsp;&nbsp;&nbsp;% | Real estate management income increased period-over-period due to an increase in origination and disposition fees as a result of rising transaction activity. |
| **Total revenue**  | **$&nbsp;&nbsp;&nbsp;&nbsp;17529&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;11955&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;47&nbsp;&nbsp;&nbsp;&nbsp;%** |  |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Three Months Ended<br>March 31, 2026**<br>*(in thousands)* | **Three Months Ended<br>March 31, 2025**<br>*(in thousands)* | **% Change**<br>*(from 2025)* | **Explanation** |
| **Costs and Expenses** | | | | |
| Cost of revenue, exclusive of depreciation and amortization shown separately below | Cost of revenue, exclusive of depreciation and amortization shown separately below, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | Cost of revenue, exclusive of depreciation and amortization shown separately below, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | Cost of revenue, exclusive of depreciation and amortization shown separately below, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | Cost of revenue, exclusive of depreciation and amortization shown separately below, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. |
| Cost of revenue, exclusive of depreciation and amortization shown separately below | $&nbsp;&nbsp;&nbsp;&nbsp;2581&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;2218&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;16&nbsp;&nbsp;&nbsp;&nbsp;% | Cost of revenue expenses increased slightly period-over-period as a result of costs associated with operating RealAI. |
| Technology and product development | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through Depreciation and amortization over the term of their useful life. All other Technology and product development expenses are expensed as incurred. | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through Depreciation and amortization over the term of their useful life. All other Technology and product development expenses are expensed as incurred. | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through Depreciation and amortization over the term of their useful life. All other Technology and product development expenses are expensed as incurred. | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through Depreciation and amortization over the term of their useful life. All other Technology and product development expenses are expensed as incurred. |
| Technology and product development | $&nbsp;&nbsp;&nbsp;&nbsp;6129&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;5560&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;10&nbsp;&nbsp;&nbsp;&nbsp;% | Technology and product development expenses increased period-over-period due to fewer salaries and benefits being capitalized to internal-use software. |
| Marketing | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. |
| Marketing | $&nbsp;&nbsp;&nbsp;&nbsp;2749&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;2216&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;24&nbsp;&nbsp;&nbsp;&nbsp;% | The increase in marketing expense period-over-period was due to increased marketing spend to support certain product marketing initiatives during the first quarter of 2026. |
| General, administrative and other | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. |
| Software and other office expenses | $&nbsp;&nbsp;&nbsp;&nbsp;713&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;650&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;10&nbsp;&nbsp;&nbsp;&nbsp;% | Software and other office expenses remained relatively consistent period-over-period and are mainly comprised of software subscription expenses supporting corporate functions and corporate office lease expense. |
| Professional fees | &nbsp;&nbsp;&nbsp;&nbsp;607&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;565&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;7&nbsp;&nbsp;&nbsp;&nbsp;% | Professional fees remained relatively consistent period-over-period and are mainly comprised of legal fees for certain advisory projects. |
| Other general and administrative | &nbsp;&nbsp;&nbsp;&nbsp;4525&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;4688&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;-3&nbsp;&nbsp;&nbsp;&nbsp;% | Other general and administrative expenses remained consistent period-over-period and are mainly comprised of salaries and benefits of personnel responsible for our corporate functions. |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| Depreciation and amortization | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. |
| Depreciation and amortization | $&nbsp;&nbsp;&nbsp;&nbsp;4474&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;3036&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;47&nbsp;&nbsp;&nbsp;&nbsp;% | Depreciation and amortization expense increased period-over-period due to (i) a $0.7 million increase in amortization of internal use software as more projects were in service in the current period, and (ii) an additional $0.7 million in accelerated amortization due to a change in useful life of an AI-related internal use software module. Refer to *<u>[Note 7](#i010073027201481f91c7f293a54ba05a_52)</u>*, *Property, Software and Equipment, net* in the Notes to the Condensed Consolidated Financial Statements for more information. |
| **Total costs and expenses**  | **$&nbsp;&nbsp;&nbsp;&nbsp;21778&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;18933&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;15&nbsp;&nbsp;&nbsp;&nbsp;%** |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Three Months Ended<br>March 31, 2026**<br>*(in thousands)* | **Three Months Ended<br>March 31, 2025**<br>*(in thousands)* | **% Change**<br>*(from 2025)* | **Explanation** |
| **Other Income** | | | | |
| Gain on extinguishment of debt | $&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;2391&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(100)&nbsp;&nbsp;&nbsp;&nbsp;% | In January 2025, the Company was notified that its Paycheck Protection Program (the "PPP loan") loan in the principal amount of $2.8 million was partially forgiven by the U.S. Small Business Administration (the "SBA") and the Company recorded a corresponding gain. Refer to *<u>[Note 8](#i010073027201481f91c7f293a54ba05a_55)</u>, Loan Payable* in the Notes to the Condensed Consolidated Financial Statements for more details.  |
| Dividend and interest income | &nbsp;&nbsp;&nbsp;&nbsp;272&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;328&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;(17)&nbsp;&nbsp;&nbsp;&nbsp;% | Dividend and interest income decreased period-over-period largely due to a decrease in sweep dividends earned, due to a lower average daily cash balance and lower interest rates. |
| Equity in earnings  | &nbsp;&nbsp;&nbsp;&nbsp;22&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;18&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;22&nbsp;&nbsp;&nbsp;&nbsp;% | Equity in earnings earned from Rise and its subsidiaries' investments in the Investment Products increased period-over-period due to the Investment Products' increase in net earnings period-over-period. |
| **Total other income**  | **$&nbsp;&nbsp;&nbsp;&nbsp;294&nbsp;&nbsp;&nbsp;&nbsp;** | **$&nbsp;&nbsp;&nbsp;&nbsp;2737&nbsp;&nbsp;&nbsp;&nbsp;** | **&nbsp;&nbsp;&nbsp;&nbsp;(89)&nbsp;&nbsp;&nbsp;&nbsp;%** |  |

---

**Key Factors Impacting Our Current Year Performance**

Our historical growth rates of the Fundrise Investment Products reflect a deliberate strategy that has allowed us to build and develop the various enterprise functions needed to meet the changing demands of our customers and to support our scale, including operations, risk controls, customer support, compliance and technology. The real estate-focused Investment Products have seen general reductions in AUM in recent years due in part to declines in certain real estate valuations and reduced transaction activity following the increase in interest rates during the early part of the decade. Through 2025 and early 2026, total AUM growth was driven by strong performance in select funds, primarily within the venture portfolio of the Innovation Fund, where investments in leading AI-focused technology companies generated higher returns. Demand from investors and broader trends in the modern financial industry will continue to inform our business and Investment Product decisions. Given this approach and the dynamic path of our experienced and expected future growth, we have focused on a number of important developments within our business that we believe reflect the key factors impacting our performance in 2026. Refer to the "Key Factors We Expect to Impact Our Future Performance" section below for a description of these key factors.

------

**Key Factors We Expect to Impact Our Future Performance**

***Investment in Long-Term Growth***

The core elements of our growth strategy include enhancing our technology infrastructure, expanding our product and feature offerings, enrolling new investors in our Investment Products, broadening our investment acquisition capabilities, and extending customer lifetime value. We plan to continue to invest resources needed to accomplish these goals, and we anticipate that certain operating expenses will increase in the future as a result. These investments are intended to contribute to our long-term growth, but they may continue to affect our near-term profitability.

***Sources of Operating Revenues and Cash Flows***

We generate revenues from investment management and platform advisory fees, real estate operating platform fees, and real estate management fees, which are detailed in *<u>Note 4</u>, Revenue* in the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report.

***Interest Rates***

During its September, October, and December 2025 meetings, the Federal Reserve (the "Fed") voted to cut its benchmark interest rate by 25 basis points each time, which was the first rate decrease since late 2024. Rates remained unchanged in the first quarter of 2026, and as of the date of this filing, the Fed has expressed uncertainty about whether rate cuts will continue. Real estate markets have faced persistent challenges following the Fed's interest rate increases beginning in late 2022. A decline in rates and improvement in market balance may positively impact real estate values in future periods, creating higher returns for our Investment Products.

**Liquidity and Capital Resources**

We have incurred operating losses since our inception and have an accumulated deficit of $187.7 million as of March 31, 2026. We have financed our operations primarily through our operating revenues as well as the issuance of equity securities. Our ability to achieve profitability depends on our ability to generate revenue growth in existing product lines, successfully launch new product lines, and manage costs. We may continue to incur substantial operating losses while we continue to build the business and invest in new innovation.

As of March 31, 2026 and December 31, 2025, we had $7.1 million and $9.2 million in cash and cash equivalents, respectively. We anticipate that our cash and cash equivalents as of March 31, 2026, and forecasted revenue, will provide sufficient liquidity for more than a twelve-month period from the date of filing this Quarterly Report. The actual amount of cash that we will need to operate is subject to many factors, including, but not limited to, our product development and engineering efforts. While we believe our existing cash resources are sufficient to fund our current operations, we may seek additional financing, including through our Offering described below under "Other Details—Offering Results" to support future growth initiatives, including the continued development and expansion of our Investment Products.

As of March 31, 2026, our material commitments for capital expenditures consisted of an operating lease, as discussed in *<u>Note 6</u>, Leases* in the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report.

***Corporate Debt***

As of March 31, 2026 and December 31, 2025, we had no corporate debt. On April 20, 2020, the Company received the PPP Loan offered by the SBA in the principal amount of $2.8 million pursuant to Title 1 of the CARES

------

Act. As explained more fully in *<u>[Note 8](#i010073027201481f91c7f293a54ba05a_55)</u>, Loan Payable*—*PPP Loan Payable* of our Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report, according to the terms of the CARES Act and subsequent regulations, all or a portion of loans under the program may be forgiven if certain conditions are met. In July 2021 we applied for such forgiveness. In January 2025, the Company was notified that the PPP loan was forgiven up to the determined eligible amount of $2.3 million. On March 19, 2025, the Company repaid the remaining $0.4 million of outstanding principal.

**Other Details**

***Offering Results***

As of March 31, 2026, we are offering up to 4,046,949 shares of our Class B Common Stock (the "Offering"), which represents the shares available to be offered out of the rolling twelve-month maximum offering amount of $75.0 million under Regulation A ("Regulation A") of the Securities Act. The Offering is being conducted as a continuous offering pursuant to Rule 251(d)(3) of Regulation A, meaning that while the offering of securities is continuous, active sales of securities may occur sporadically over the term of the Offering. As of March 31, 2026, we had raised total gross offering proceeds of approximately $215.2 million from settled subscriptions.

As of March 31, 2026, we have sold 21,571,758 shares of our Class B Common Stock pursuant to the Offering and our prior Regulation A offerings.

Shares are currently offered and are sold on a continuous basis only to existing investors in the Investment Products. The funds received from the issuance of our Class B Common Stock are a source of capital for our operating expenditures.

***Off-Balance Sheet Arrangements***

As of March 31, 2026 and December 31, 2025, we had no off-balance sheet arrangements.

***Related Party Arrangements***

For further information regarding "Related Party Arrangements," please see *<u>[Note 15](#i010073027201481f91c7f293a54ba05a_76)</u>, Related Party Transactions*, in our Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report.

***Critical Accounting Estimates***

Management's Discussion and Analysis of Financial Condition and Results of Operations in this Quarterly Report is based on our Notes to the Condensed Consolidated Financial Statements, which are prepared in accordance with U.S. GAAP. The preparation of these Condensed Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. By their nature, these estimates and assumptions are subject to an inherent degree of uncertainty and actual results could differ significantly from the estimates made by management. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations, and cash flows will be affected. For a complete description of our accounting policies, see *<u>[Note 2](#i010073027201481f91c7f293a54ba05a_37)</u>, Summary of Significant Accounting Policies* in our Notes to the Consolidated Financial Statements included in the Form 10-K.

The Company's critical accounting estimates are disclosed in the Form 10-K. There have been no material changes to these estimates during the three months ended March 31, 2026, and no significant updates were made to the underlying methodologies or assumptions since the date of the Form 10-K other than as noted below.

------

***Estimated Useful Life of Internal-Use Software***

The Company amortizes capitalized internal-use software on a straight-line basis over the estimated useful life of each module, which requires management judgment regarding the expected period of economic benefit, anticipated future development activity, and the potential for technological change to render existing functionality obsolete.

During the three months ended March 31, 2026, the Company revised the estimated useful life of an AI-related internal-use software module from four years to one year, increasing amortization expense by approximately $0.7 million for the three months ended March 31, 2026. The remaining carrying value of approximately $1.8 million will be amortized through September 2026. Changes in the anticipated timing or scope of future development activity could require further revision of this estimate or other internal use software module estimates, which may have a material effect on amortization expense in future periods.

***Recent Accounting Pronouncements***

The Financial Accounting Standards Board has released several Accounting Standards Updates ("ASUs") that may have an impact on our Condensed Consolidated Financial Statements. See *<u>[Note 2](#i010073027201481f91c7f293a54ba05a_37)</u>, Summary of Significant Accounting Policies*—*Recent Accounting Pronouncements* in the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report for discussion of the relevant ASUs. We are currently evaluating the impact of the ASUs not yet adopted on our Financial Statements and determining our plan for adoption.

**Item 3.&nbsp;&nbsp;&nbsp;&nbsp;Quantitative and Qualitative Disclosures About Market Risk**

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Controls and Procedures**

***Disclosure Controls and Procedures***

An evaluation of the effectiveness of the design and operation of our "disclosure controls and procedures" (as defined in Rule 13a-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report was made under the supervision and with the participation of our management, including our Chief Executive Officer ("CEO"), our principal executive officer, and our Chief Financial Officer ("CFO"), our principal financial officer. Based upon this evaluation, our CEO and CFO have concluded that our disclosure controls and procedures as of the end of the period covered by this Quarterly Report (a) are effective to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by SEC rules and forms and (b) include, without limitation, controls and procedures designed to ensure that information required by us in reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on

------

certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

***Changes in Internal Control over Financial Reporting***

There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2026 (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II - OTHER INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Legal Proceedings**

As of the date of the Condensed Consolidated Financial Statements, we are not currently named as a defendant in any active or pending material litigation. However, it is possible that the Company could become involved in various litigation matters arising in the ordinary course of our business. Although we are unable to predict with certainty the eventual outcome of any litigation, management is not aware of any litigation likely to occur that we currently assess as being significant to us.

**Item 1A.&nbsp;&nbsp;&nbsp;&nbsp;Risk Factors**

We face risks and uncertainties that could affect us and our business as well as the real estate industry generally. These risks are outlined under the heading "Risk Factors" contained in the Form 10-K. In addition, new risks may emerge at any time and we cannot predict such risks or estimate the extent to which they may affect our financial performance. These risks could result in a decrease in the value of our common shares. Other than the below, there have been no material changes in our risk factors from those described in the Form 10-K.

***Geopolitical instability, including ongoing conflicts in Iran, and a prolonged period of elevated or rising interest rates could adversely impact our business, financial condition and results of operations.***

Geopolitical tensions and armed conflicts, including the ongoing conflicts in Iran, have increased global economic uncertainty and contributed to volatility in financial markets, energy prices and capital flows. The continuation or escalation of such conflicts, or the expansion of such conflicts into neighboring regions, could disrupt global supply chains, increase inflationary pressures and lead to further instability in credit and equity markets. These developments may negatively impact investor sentiment, reduce capital formation and limit the availability of financing for real estate and other investments held by our Investment Products.

In addition, central banks, including the Fed, have maintained or may further implement restrictive monetary policies in response to inflation and geopolitical risks. Sustained higher interest rates, or further increases in interest rates, have and may continue to adversely affect real estate values, transaction activity and the availability and cost of debt financing. As disclosed in our Form 10-K, our real estate investments are subject to risks associated with rising interest rates and adverse market conditions. Higher borrowing costs and capitalization rates may reduce property valuations, increase debt service obligations and decrease returns on our Investment Products.

These factors may also reduce demand for real estate, delay or prevent development and refinancing activities, and increase the likelihood of tenant defaults or vacancies across our portfolio. In addition, market volatility and uncertainty may lead to reduced investor demand for our Investment Products or increased redemption activity, which could adversely affect our revenues, which are primarily derived from fees based on assets under management.

The extent to which geopolitical conflicts and interest rate conditions impact our business will depend on numerous evolving factors, including the duration and severity of such conflicts, governmental and central bank responses, and the resulting effects on global and U.S. economic conditions. Any of the foregoing could materially and adversely affect our business, financial condition and results of operations.

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;Unregistered Sales of Equity Securities and Use of Proceeds**

***Sales Pursuant to the Offering and our Private Placements***

------

As disclosed under the heading "Other Details - Offering Results," we are offering 4,046,949 shares of our Class B Common Stock pursuant to the Offering. During the three months ended March 31, 2026, we have sold 236,326 shares of Class B Common Stock pursuant to the Offering for aggregate proceeds of approximately $3,758,000.

In reliance upon the exemptions from registration under the Securities Act provided by Regulation A, none of the sales of our Common Stock described above were registered under the Securities Act.

***Repurchases of Equity Securities***

During the three months ended March 31, 2026, we repurchased shares of our Common Stock pursuant to certain discretionary investor redemptions as noted in the table below. The Company does not currently have a publicly announced share repurchase program.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of Shares** <br>**Purchased** | **Average Price Paid Per Share** | **Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs** | **Maximum Number (or Approximate Dollar value) of Shares That May Yet Be Purchased Under the Plans or Programs** |
| January 1, 2026 – January 31, 2026 | &nbsp;&nbsp;&nbsp;&nbsp;6019&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;11.75&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |
| February 1, 2026 – February 28, 2026 | &nbsp;&nbsp;&nbsp;&nbsp;187&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;10.69&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |
| March 1, 2026 – March 31, 2026 | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | $&nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; | &nbsp;&nbsp;&nbsp;&nbsp;—&nbsp;&nbsp;&nbsp;&nbsp; |

---

**Item 3.&nbsp;&nbsp;&nbsp;&nbsp;Defaults Upon Senior Securities**

None.

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Mine Safety Disclosures**

Not applicable.

**Item 5.&nbsp;&nbsp;&nbsp;&nbsp;Other Information**

None.